<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>The European Journal of Health Economics via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'The European Journal of Health Economics' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=The+European+Journal+of+Health+Economics&t=The+European+Journal+of+Health+Economics&s=Search&f=source]]></link>
        <lastBuildDate>Thu, 09 Feb 2012 10:13:06 +0100</lastBuildDate>
        <item>
            <title>The impact of health insurance mandates on drug innovation: evidence from the United States</title>
            <link>http://www.medworm.com/index.php?rid=5663386&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F152pu521g7jh6776%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;An important health policy issue is the low rate of patient enrollment into clinical trials, which may slow down the process
 of clinical trials and discourage their supply, leading to delays in innovative life-saving drug treatments reaching the general
 population. In the US, patients’ cost of participating in a clinical trial is considered to be a major barrier to patient
 enrollment. In order to reduce this barrier, some states in the US have implemented policies requiring health insurers to
 cover routine care costs for patients enrolled in clinical trials. This paper evaluates empirically how effective these policies
 were in increasing the supply of clinical trials and speeding up their completion, using data on cancer clinical trials initiated
 in the US betwe...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663386</comments>
            <pubDate>Tue, 31 Jan 2012 07:09:29 +0100</pubDate>
            <guid isPermaLink="false">5663386</guid>        </item>
        <item>
            <title>Impact of parallel trade on pharmaceutical firm’s profits: rise or fall?</title>
            <link>http://www.medworm.com/index.php?rid=5654824&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq17667651015m7j4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Most existing studies on parallel trade conclude that it reduces pharmaceutical firms’ profits. One special feature of the
 pharmaceutical industry is the presence of price regulation in most countries. Taking into account the impact of parallel
 trade on the regulated pharmaceutical prices [Pecorino, P.: J. Health Econ. 21, 699–708 (2002)] shows that a pharmaceutical firm’s profit is greater in the presence of parallel trade. The present paper
 relaxes the assumption on identical demands among countries, and takes into account transaction costs. The results of our
 model show that a firm’s profits may increase or decrease in the presence of parallel trade, depending on its bargaining power
 in the price negotiation and market size of the drug. Changes in social...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5654824</comments>
            <pubDate>Sat, 28 Jan 2012 16:50:24 +0100</pubDate>
            <guid isPermaLink="false">5654824</guid>        </item>
        <item>
            <title>Rationing and deprivation: disease-modifying therapies for multiple sclerosis in the United Kingdom</title>
            <link>http://www.medworm.com/index.php?rid=5642500&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5505347637l57845%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Unlike other industrialised countries, the UK deferred the routine introduction of disease-modifying therapies (DMTs) for
 multiple sclerosis (MS) in favour of an experiment. Between 2002 and 2005, MS sufferers were identified, were offered DMTs
 only if deemed suitable by their physicians, and were monitored thereafter to assess long-term outcomes. It has been demonstrated
 for other therapies that judgements about suitability to receive treatment are conditioned by the patient’s deprivation status.
 We hypothesised that this would have been the case for DMTs also. Using individual patient data for samples in Nottingham
 and in Glasgow, we matched patients’ postcodes of residence with deprivation scores and confirmed that patients from more
 deprived areas were les...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642500</comments>
            <pubDate>Tue, 24 Jan 2012 06:44:33 +0100</pubDate>
            <guid isPermaLink="false">5642500</guid>        </item>
        <item>
            <title>Longitudinal predictive ability of mapping models: examining post-intervention EQ-5D utilities derived from baseline MHAQ data in rheumatoid arthritis patients</title>
            <link>http://www.medworm.com/index.php?rid=5615739&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk40pur727x1v83lg%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;This study builds upon existing research having demonstrated the potential usefulness of mapping disease-specific instruments
 onto utility measures. The specific issue of longitudinal validity is addressed, as mapping models derived from baseline patients
 need to be validated on post-therapy samples. The underestimation of post-treatment utilities in the present study, at least
 in more severe patients, warrants further research before it is prudent to conduct cost-utility analyses in the context of
 RA by means of the MHAQ alone.
 
 
 
 
	Content Type Journal ArticleCategory Original PaperPages 1-8DOI 10.1007/s10198-012-0376-9Authors
		Nick Kontodimopoulos, Faculty of Social Sciences, Hellenic Open University, Bouboulinas 57, 26222 Patras, GreecePanagiotis Bozios,...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615739</comments>
            <pubDate>Wed, 18 Jan 2012 06:59:03 +0100</pubDate>
            <guid isPermaLink="false">5615739</guid>        </item>
        <item>
            <title>Time to incorporate time in cost-effectiveness analysis</title>
            <link>http://www.medworm.com/index.php?rid=5615740&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft66p38n31261v724%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Cost-effectiveness analysis as a means to evaluate medical innovations has become well accepted in the UK and several other
 Western countries. An important assumption underlying this method is that costs and effects are constant over time. In reality,
 however, and especially in the short run, variations in costs and effects are likely to occur. These variations can lead to
 considerable deviations from the outcome of a conventional economic evaluation, which in turn may lead to serious implementation
 problems at a local level. Taking time into account explicitly in economic evaluations in health care may enhance their utility
 for both societal and local decision making, and may ultimately smooth the adoption of new and basically cost-effective health
 care technolog...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615740</comments>
            <pubDate>Wed, 18 Jan 2012 06:59:02 +0100</pubDate>
            <guid isPermaLink="false">5615740</guid>        </item>
        <item>
            <title>What can we learn from international comparisons of costs by DRG?</title>
            <link>http://www.medworm.com/index.php?rid=5591070&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Flp4ll78860746064%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;It is possible to make international comparisons but only if there is standardization of the case-mix between countries and
 only if comparable accountancy methodologies are used. Harmonization of DRGs groups, nomenclature and accountancy is thus
 required.
 
 
 
 
	Content Type Journal ArticleCategory Original PaperPages 1-7DOI 10.1007/s10198-011-0373-4Authors
		M. Pirson, Unité Economie et Gestion des Institutions de Soins, Département d’économie de la santé, Ecole de Santé Publique, Université Libre de Bruxelles, 808, Route de Lennik, CP592, 1070 Bruxelles, BelgiumL. Schenker, Institute of Health Economics and Management, University of Lausanne and APDRG Suisse, Lausanne, SwitzerlandD. Martins, Unité Economie et Gestion des Institutions de Soins, Départe...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5591070</comments>
            <pubDate>Wed, 11 Jan 2012 17:57:38 +0100</pubDate>
            <guid isPermaLink="false">5591070</guid>        </item>
        <item>
            <title>Moving beyond a limited follow-up in cost-effectiveness analyses of behavioral interventions</title>
            <link>http://www.medworm.com/index.php?rid=5575584&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc8078580775q6h36%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;This study showed that modeling of future behavioral change in CEA of a behavioral intervention further strengthened the results
 of the standard CEA. Ultimately, modeling future behavioral change could have important consequences for health policy development
 in general and the adoption of behavioral interventions in particular.
 
 
 
 
	Content Type Journal ArticleCategory Original PaperPages 1-10DOI 10.1007/s10198-011-0371-6Authors
		Rilana Prenger, Department of Psychology, Health and Technology, University of Twente, PO Box 217, 7500 AE Enschede, The NetherlandsMarcel E. Pieterse, Department of Psychology, Health and Technology, University of Twente, PO Box 217, 7500 AE Enschede, The NetherlandsLouise M. A. Braakman-Jansen, Department of Psychology, Health and T...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5575584</comments>
            <pubDate>Thu, 05 Jan 2012 17:08:16 +0100</pubDate>
            <guid isPermaLink="false">5575584</guid>        </item>
        <item>
            <title>Medical guidelines, physician density, and quality of care: evidence from German SHARE data</title>
            <link>http://www.medworm.com/index.php?rid=5556172&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F92306746r4t03074%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We use German SHARE data to study the relationship between district general practitioner density and the quality of preventive
 care provided to older adults. We measure physician quality of care as the degree of adherence to medical guidelines (for
 the management of risk factors for cardiovascular disease and the prevention of falls) as reported by patients. Contrary to
 theoretical expectations, we find only weak and insignificant effects of physician density on quality of care. Our results
 shed doubt on the notion that increasing physician supply will increase the quality of care provided in Germany’s present
 health care system.
 
 
	Content Type Journal ArticleCategory Original PaperPages 1-15DOI 10.1007/s10198-011-0372-5Authors
		Hendrik Jürges, Schumpeter Sc...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5556172</comments>
            <pubDate>Tue, 27 Dec 2011 17:02:06 +0100</pubDate>
            <guid isPermaLink="false">5556172</guid>        </item>
        <item>
            <title>Endogenous technological change in medicine and its impact on healthcare costs: evidence from the pharmaceutical market in Taiwan</title>
            <link>http://www.medworm.com/index.php?rid=5556173&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq6604283k3u85607%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Although the technological change in medicine has been recognized widely as the major driver of rising healthcare costs, there
 is very little research that estimates this effect directly. This paper uses both a single-equation and a simultaneous equations
 approach to investigate empirically the interactive relationship between technological innovation and the growth of health
 expenditure in the context of the pharmaceutical market in Taiwan. Based on observing 182 therapeutic groups between 1997
 and 2006, we find evidence to support the argument that technological innovation and health expenditure are determined simultaneously
 as technological innovation, and that the growth of health expenditure are endogenous rather than exogenous. Specifically,
 we find that the...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5556173</comments>
            <pubDate>Mon, 26 Dec 2011 16:44:55 +0100</pubDate>
            <guid isPermaLink="false">5556173</guid>        </item>
        <item>
            <title>Using respondents’ uncertainty scores to mitigate hypothetical bias in community-based health insurance studies</title>
            <link>http://www.medworm.com/index.php?rid=5499930&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ful0538p271157036%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Community-based health insurance has been implemented in several developing countries to help the poor to gain access to adequate
 health-care services. Assessing what the poor are willing to pay is of paramount importance for policymaking. The contingent
 valuation method, which relies on a hypothetical market, is commonly used for this purpose. But the presence of the hypothetical
 bias that is most often inherent in this method tends to bias the estimates upward and compromises policymaking. This paper
 uses respondents’ uncertainty scores in an attempt to mitigate hypothetical bias in community-based health insurance in one
 rural setting in Cameroon. Uncertainty scores are often employed in single dichotomous choice surveys. An originality of the
 paper is to use...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5499930</comments>
            <pubDate>Fri, 09 Dec 2011 17:04:17 +0100</pubDate>
            <guid isPermaLink="false">5499930</guid>        </item>
        <item>
            <title>Determinants of healthcare system’s efficiency in OECD countries</title>
            <link>http://www.medworm.com/index.php?rid=5491514&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw823136473812206%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Countries striving to improve their HSE should aim to impact population behavior and welfare rather than only ensure adequate
 medical care. In addition, they may consider avoiding specific institutional arrangements, namely gatekeeping and the presence
 of multiple insurers. Finally, the ambiguous association found between socioeconomic and environmental indicators, and a country’s
 HSE necessitates caution when interpreting different ranking techniques in a cross-country efficiency evaluation and needs
 further exploration.
 
 
 
 
	Content Type Journal ArticleCategory Original PaperPages 1-13DOI 10.1007/s10198-011-0366-3Authors
		Sharon Hadad, Department of Industrial Engineering and Management, Shamoon College of Engineering, Beer-Sheva, IsraelYossi Hadad, Depa...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5491514</comments>
            <pubDate>Tue, 06 Dec 2011 17:03:07 +0100</pubDate>
            <guid isPermaLink="false">5491514</guid>        </item>
        <item>
            <title>Organisational determinants of production and efficiency in general practice: a population-based study</title>
            <link>http://www.medworm.com/index.php?rid=5481754&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff734244u52333617%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Nurses are currently undertaking other tasks than GPs, and larger practices do not lead to increased production per GP. However,
 a relative increase in list size increased the efficiency. This indicates that organisational changes aiming to increase capacity
 in general practice should be carefully designed and tested.
 
 
 
 
	Content Type Journal ArticleCategory Original PaperPages 1-10DOI 10.1007/s10198-011-0368-1Authors
		Kim Rose Olsen, Danish Institute for Health Services Research, Copenhagen, DenmarkDorte Gyrd-Hansen, Danish Institute for Health Services Research, Copenhagen, DenmarkTorben Højmark Sørensen, Danish Institute for Health Services Research, Copenhagen, DenmarkTroels Kristensen, Research Unit of Health Economics, University of Southern Denmark, ...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5481754</comments>
            <pubDate>Mon, 05 Dec 2011 17:34:09 +0100</pubDate>
            <guid isPermaLink="false">5481754</guid>        </item>
        <item>
            <title>Patient socioeconomic determinants for the choice of the cheapest molecule within a cluster: evidence from Belgian prescription data</title>
            <link>http://www.medworm.com/index.php?rid=5472895&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2kh2hp74034u2654%2F</link>
            <description>This study analyzed for a sample of Belgian individual prescription data for 4
 clusters of commonly used drugs (proton pump inhibitors, statins and two groups of antihypertensives [drugs acting on renin-angiotensin
 system and dihydropyridine derivatives]) whether the probability to receive the least expensive molecule within a cluster
 was linked to the socioeconomic status of the patient. Logistic regression models included individual demographic, working,
 chronic illness and financial status and small area education data for 906,543 prescriptions from 1,280 prescribing general
 practitioners and specialists. For the 4 clusters, results show that patients with lower socioeconomic status consistently
 use slightly more the least expensive drugs than other patients. Larger effects are ob...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5472895</comments>
            <pubDate>Fri, 02 Dec 2011 17:13:58 +0100</pubDate>
            <guid isPermaLink="false">5472895</guid>        </item>
        <item>
            <title>The influence of social deprivation on length of hospitalisation</title>
            <link>http://www.medworm.com/index.php?rid=5436270&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe545p46821611026%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The implementation of activity-based payment system named T2A—tarification à l’activité—in 2004 profoundly modified the financing of French hospitals. Presently applied to activities concerning medicine, surgery
 and obstetrics, the pricing for these activities was developed using the National Costs Study. The considerable differences
 observed between costs in the private sector and those in the public sector are in part justified, by the latter, by caring
 for patients with social deprivation. The goal of this study is to measure the influence of social deprivation on the length
 of hospitalisation. A survey on inpatient social deprivation was carried out from November to December 2008 by the French
 Ministry of Health (Department of Research, Study, Evaluatio...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5436270</comments>
            <pubDate>Fri, 18 Nov 2011 06:59:37 +0100</pubDate>
            <guid isPermaLink="false">5436270</guid>        </item>
        <item>
            <title>Trends in social class inequalities in the use of health care services within the Spanish National Health System, 1993–2006</title>
            <link>http://www.medworm.com/index.php?rid=5415770&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3136v00h3q1634g8%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Despite the increase in the use of health care services, the relationship between social class and the use of these services
 has remained stable throughout the study period. Achieving equity in the use of specialised care services is still a challenge
 for universal health care systems.
 
 
 
 
	Content Type Journal ArticleCategory Original PaperPages 1-9DOI 10.1007/s10198-011-0362-7Authors
		Laia Palència, CIBER de Epidemiología y Salut Pública (CIBERESP), Madrid, SpainAlbert Espelt, CIBER de Epidemiología y Salut Pública (CIBERESP), Madrid, SpainMaica Rodríguez-Sanz, CIBER de Epidemiología y Salut Pública (CIBERESP), Madrid, SpainKatia B. Rocha, Agència de Salut Pública de Barcelona, Plaça Lesseps 1, 08023 Barcelona, SpainM. Isabel Pasarín, CIBER de Ep...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5415770</comments>
            <pubDate>Wed, 09 Nov 2011 17:46:53 +0100</pubDate>
            <guid isPermaLink="false">5415770</guid>        </item>
        <item>
            <title>Does participation in clinical trials influence the costs of future management of patients?</title>
            <link>http://www.medworm.com/index.php?rid=5415771&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2151q2606578186k%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Although we did not find any statistical significant differences in health care costs, we did observe a higher consumption
 of prescribed medication and lower costs of work hours lost if both patient and GPs participated in a former clinical trial.
 The results may be limited due to a lower number of patients included than expected.
 
 
 
 
	Content Type Journal ArticleCategory Original PaperPages 1-6DOI 10.1007/s10198-011-0359-2Authors
		Anne Hvenegaard, Danish Institute for Health Services Research, 27-29 Dampfaergevej, 2100 Copenhagen, DenmarkHenrik Hauschildt Juhl, Danish Institute for Health Services Research, 27-29 Dampfaergevej, 2100 Copenhagen, DenmarkAndreas Habicht, Signifikans ApS, Rundforbivej 2 (Trørød), 2950 Vedbæk, Denmark
	

	
		Journal The European...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5415771</comments>
            <pubDate>Wed, 09 Nov 2011 17:46:52 +0100</pubDate>
            <guid isPermaLink="false">5415771</guid>        </item>
        <item>
            <title>The impact of using different tariffs to value EQ-5D health state descriptions: an example from a study of acute cough/lower respiratory tract infections in seven countries</title>
            <link>http://www.medworm.com/index.php?rid=5394697&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fxrk9256827040w38%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;When using the EQ-5D in European cross-national studies, there is no consensus over whether the European value set (EVS),
 country specific value sets (CVS) or UK value set (UKVS) should be used. Data on health outcomes were collected in 7 countries.
 EQ-5D index scores were generated for each country using all three value sets. QALYs gained over 4&amp;nbsp;weeks based on EQ-5D scores
 were also generated in order to investigate the implications for cost-utility analysis. EQ-5D scores obtained using the EVS
 were similar to values obtained using the CVS and UKVS in all countries. CVS-based EQ-5D scores were on average associated
 with a smaller baseline-to-week 4 change/improvement in all countries (except in Wales and Belgium) while UKVS-based EQ-5D
 scores showed the larg...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5394697</comments>
            <pubDate>Fri, 04 Nov 2011 16:54:14 +0100</pubDate>
            <guid isPermaLink="false">5394697</guid>        </item>
        <item>
            <title>An analysis of the influence of framework aspects on the study design of health economic modeling evaluations</title>
            <link>http://www.medworm.com/index.php?rid=5394696&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7x8h2566vn210j05%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Research and practical guidelines have many implications for how to structure a health economic study. A major focus in recent
 decades has been the quality of health economic research. In practice, the factors influencing a study design are not limited
 to the quest for quality. Moreover, the framework of the study is important. This research addresses three major questions
 related to these framework aspects. First, we want to know whether the design of health economic studies has changed over
 time. Second, we want to know how the subject of a study, whether it is a process or product innovation, influences the parameters
 of the study design. Third, one of the most important questions we will answer is whether and how the study’s source of funding
 has an impact o...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5394696</comments>
            <pubDate>Fri, 04 Nov 2011 16:54:14 +0100</pubDate>
            <guid isPermaLink="false">5394696</guid>        </item>
        <item>
            <title>Mapping utility scores from the Barthel index</title>
            <link>http://www.medworm.com/index.php?rid=5394698&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa087427q242w3k15%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;It is possible to reasonably predict that the EQ-5D from the Barthel using regression methods and the CLAD model (4) is recommended.
 
 
 
	Content Type Journal ArticleCategory Original PaperPages 1-11DOI 10.1007/s10198-011-0364-5Authors
		Billingsley Kaambwa, Health Economics Unit, Public Health Building, University of Birmingham, Edgbaston, Birmingham, B15 2TT UKLucinda Billingham, Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Edbaston, Birmingham, B15 2TT UKStirling Bryan, Centre for Clinical Epidemiology and Evaluation, University of British Columbia, Research Pavilion, 702-828 West 10th Ave, Vancouver, BC, Canada
	

	
		Journal The European Journal of Health EconomicsOnline ISSN 1618-7601Print ISSN 1618-7598 (Source: The European Jou...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5394698</comments>
            <pubDate>Tue, 01 Nov 2011 16:52:35 +0100</pubDate>
            <guid isPermaLink="false">5394698</guid>        </item>
        <item>
            <title>Epilepsy in Sweden: health care costs and loss of productivity—a register-based approach</title>
            <link>http://www.medworm.com/index.php?rid=5372346&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F637612t521152817%2F</link>
            <description>The objective was to estimate health care costs and productivity losses due to epilepsy in Sweden and to compare these estimates
 to previously published estimates.
 
 
 
 
 Methods&amp;nbsp;&amp;nbsp;Register data on health care utilisation, pharmaceutical sales, permanent disability and mortality were used to calculate
 health care costs and costs that accrue due to productivity losses. By linkage of register information, we were able to distinguish
 pharmaceuticals prescribed against epilepsy from prescriptions that were prompted by other indications.
 
 
 
 
 Results&amp;nbsp;&amp;nbsp;The estimated total cost of epilepsy in Sweden in 2009 was &amp;#8364;441 million, which corresponds to an annual per-patient cost of
 &amp;#8364;8,275. Health care accounted for about 16% of the estimated total cost, and drug ...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5372346</comments>
            <pubDate>Mon, 31 Oct 2011 17:00:47 +0100</pubDate>
            <guid isPermaLink="false">5372346</guid>        </item>
        <item>
            <title>Is it time to reconsider the role of patient co-payments for pharmaceuticals in Europe?</title>
            <link>http://www.medworm.com/index.php?rid=5372347&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Flk5g4u7j10683438%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-5DOI 10.1007/s10198-011-0353-8Authors
		Michael Drummond, Centre for Health Economics, University of York, Alcuin A Block, Heslington, York, YO10 5DD UKAdrian Towse, Office of Health Economics, London, UK
	

	
		Journal The European Journal of Health EconomicsOnline ISSN 1618-7601Print ISSN 1618-7598 (Source: The European Journal of Health Economics)</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5372347</comments>
            <pubDate>Mon, 31 Oct 2011 17:00:43 +0100</pubDate>
            <guid isPermaLink="false">5372347</guid>        </item>
        <item>
            <title>Self-control and support for anti-smoking policies among smokers, ex smokers, and never smokers</title>
            <link>http://www.medworm.com/index.php?rid=5353825&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm317tg5458710131%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In this paper, we sustain that non-smokers who might be at risk of starting to smoke or relapsing can benefit from anti-smoking
 policies such as tax hikes and smoking bans because these are mechanisms that enhance their self-control with regard to tobacco
 consumption. We formalize this conjecture by proposing a model where starting/relapsing might result from time inconsistent
 preferences in a way that mirrors the inability of some smokers to carry out the decision to quit. Subsequently, we specify
 econometric models that allow us to test the implications of such conjecture using information on smoking behavior at the
 individual level from the Catalan Health Survey of 2006. The empirical results support our conjecture and suggest that the
 welfare gains derived fro...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5353825</comments>
            <pubDate>Fri, 21 Oct 2011 05:46:31 +0100</pubDate>
            <guid isPermaLink="false">5353825</guid>        </item>
        <item>
            <title>Economic evaluation of URMEL-ICE, a school-based overweight prevention programme comprising metabolism, exercise and lifestyle intervention in children</title>
            <link>http://www.medworm.com/index.php?rid=5320218&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj26163j277463611%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The study gives new information about the cost-effectiveness of structured health promotion embedded in daily routine at primary
 schools. Assuming a MWTP of &amp;#8364;35 the intervention is cost-effective with a positive NMB. This result may help decision makers
 in implementing programmes to prevent childhood overweight in school settings.
 
 
 
 
	Content Type Journal ArticleCategory Original PaperPages 1-11DOI 10.1007/s10198-011-0358-3Authors
		Dorothea Kesztyüs, Division of Sports and Rehabilitation, Department of Internal Medicine II, Ulm University Medical Centre, Frauensteige 6, Haus 58/33, 89075 Ulm, GermanyAnja Schreiber, Division of Sports and Rehabilitation, Department of Internal Medicine II, Ulm University Medical Centre, Frauensteige 6, Haus 58/33, 89075...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5320218</comments>
            <pubDate>Tue, 11 Oct 2011 05:51:49 +0100</pubDate>
            <guid isPermaLink="false">5320218</guid>        </item>
        <item>
            <title>The welfare implications of disability for older people in Ireland</title>
            <link>http://www.medworm.com/index.php?rid=5300927&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8562964g29h24172%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Recent data analysed for Ireland suggest a strong link between disability status and household poverty, while there exists
 substantial evidence to suggest that disability is highly prevalent among persons of older age. Within this context, this
 paper estimates the welfare implications of disability for older people in Ireland. We define and estimate models of the private
 costs borne by households with older persons who have a disability in Ireland, both in general and by severity of illness
 or condition. Our modelling framework is based on the standard of living approach to estimating the cost of disability. The
 model quantifies the extra costs of living associated with disability and is estimated by comparing the standard of living
 of households with and without ...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5300927</comments>
            <pubDate>Fri, 07 Oct 2011 16:00:41 +0100</pubDate>
            <guid isPermaLink="false">5300927</guid>        </item>
        <item>
            <title>Cost-effectiveness of open versus laparoscopic appendectomy: a multilevel approach with propensity score matching</title>
            <link>http://www.medworm.com/index.php?rid=5300928&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fxk8374285708h7n8%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Predicted costs for LA were 1,856 US$ lower than for OA while the postoperative complication rate did not differ significantly.
 Thus, LA is the treatment of choice from a provider’s perspective.
 
 
 
 
	Content Type Journal ArticleCategory Original PaperPages 1-12DOI 10.1007/s10198-011-0355-6Authors
		Laura Haas, Institute of Health Economics and Health Care Management, Helmholtz Zentrum Muenchen, Ingolstädter Landstr. 1, 85764 Neuherberg/Munich, GermanyTom Stargardt, Institute of Health Economics and Health Care Management, Helmholtz Zentrum Muenchen, Ingolstädter Landstr. 1, 85764 Neuherberg/Munich, GermanyJonas Schreyoegg, Institute of Health Economics and Health Care Management, Helmholtz Zentrum Muenchen, Ingolstädter Landstr. 1, 85764 Neuherberg/Munich, G...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5300928</comments>
            <pubDate>Fri, 07 Oct 2011 16:00:39 +0100</pubDate>
            <guid isPermaLink="false">5300928</guid>        </item>
        <item>
            <title>Comparison of health state utility values derived using time trade-off, rank and discrete choice data anchored on the full health-dead scale</title>
            <link>http://www.medworm.com/index.php?rid=5280144&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft541l3017pn60887%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Recent years have seen increasing interest in the use of ordinal methods to elicit health state utility values as an alternative
 to conventional methods such as standard gamble and time trade-off (TTO). However, in order to use these ordinal methods to
 produce health state values for use in cost-effectiveness analysis using cost per quality adjusted life year (QALY) analysis,
 these values must be anchored on the full health-dead scale. The paper reports on two feasibility studies that use two approaches
 to anchor health state utility values derived from discrete choice data on the full health-dead scale: normalising using (1)
 the TTO value of the worst state and (2) the coefficient on the ‘dead’ dummy variable. Health state utility values obtained
 using rank a...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5280144</comments>
            <pubDate>Fri, 30 Sep 2011 06:22:53 +0100</pubDate>
            <guid isPermaLink="false">5280144</guid>        </item>
        <item>
            <title>The impact of new (orphan) drug approvals on premature mortality from rare diseases in the United States and France, 1999–2007</title>
            <link>http://www.medworm.com/index.php?rid=5280145&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw8g76t4p5g484787%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;This paper investigates the impact of the introduction of new orphan drugs on premature mortality from rare diseases using
 longitudinal, disease-level data obtained from a number of major databases. The analysis is performed using data from two
 countries: the United States (during the period 1999–2006) and France (during the period 2000–2007). For both countries, we
 estimate models using two alternative definitions of premature mortality, several alternative criteria for inclusion in the
 set of rare diseases, and several values of the potential lag between new drug approvals and premature mortality reduction.
 Both the United States and French estimates indicate that, overall, premature mortality from rare diseases is unrelated to
 the cumulative number of drugs...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5280145</comments>
            <pubDate>Wed, 28 Sep 2011 05:53:25 +0100</pubDate>
            <guid isPermaLink="false">5280145</guid>        </item>
        <item>
            <title>Determinants of household direct and indirect costs: an insight for health-seeking behaviour in Burkina Faso</title>
            <link>http://www.medworm.com/index.php?rid=5280146&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm731u07r7021u373%2F</link>
            <description>The objective of the study is to identify the determinants of household direct and indirect costs in the Nouna District, Burkina
 Faso. The data used were from a household survey conducted during 2000–2001. The multinominal logit models were applied to
 investigate the determinants of direct and indirect costs. The respondents who were sick in the rainy season and severity
 of illness significantly increased the probability of having high direct and indirect household costs. Acute illness occured
 in an adult was positively associated with magnitude of household indirect costs. Household economic status and utilization
 of western medical care played an important role in magnitude of direct cost. The information on determinants of household
 direct and indirect costs is necessary in orde...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5280146</comments>
            <pubDate>Wed, 28 Sep 2011 05:53:24 +0100</pubDate>
            <guid isPermaLink="false">5280146</guid>        </item>
        <item>
            <title>Food prices and overweight patterns in Italy</title>
            <link>http://www.medworm.com/index.php?rid=5256193&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe1pk453v74v1427l%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In this paper, we examine the role of relative food prices in determining the recent increase in body weight in Italy. Cross-price
 elasticities of unhealthy and healthy foods estimated by a demand system provide a consistent framework to evaluate substitution
 effects, when a close association is assumed between unhealthy (healthy) foods and more (less) energy-dense foods. We used
 a dataset constructed from a series of cross-sections of the Italian Household Budget Survey (1997–2005) to obtain the variables
 of the demand system, which accounts for regional price variability. The relative increase in healthy food prices was found
 to produce nontrivial elasticities of substitution towards higher relative consumption of unhealthy foods, with effects on
 weight outcom...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5256193</comments>
            <pubDate>Wed, 21 Sep 2011 05:53:47 +0100</pubDate>
            <guid isPermaLink="false">5256193</guid>        </item>
        <item>
            <title>Valuing EQ-5D using Time Trade-Off in France</title>
            <link>http://www.medworm.com/index.php?rid=5256194&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5130q1460234v456%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;This study provides the French value set of the EQ-5D based on the stated preferences of the French general public facilitating
 cost-effectiveness analysis.
 
 
 
 
	Content Type Journal ArticleCategory Original PaperPages 1-10DOI 10.1007/s10198-011-0351-xAuthors
		Julie Chevalier, Chair of Health Economics and Management, ESSEC Business School, Avenue Bernard Hirsch, BP 50105, 95021 Cergy-Pontoise Cedex, FranceGérard de Pouvourville, Chair of Health Economics and Management, ESSEC Business School, Avenue Bernard Hirsch, BP 50105, 95021 Cergy-Pontoise Cedex, France
	

	
		Journal The European Journal of Health EconomicsOnline ISSN 1618-7601Print ISSN 1618-7598 (Source: The European Journal of Health Economics)</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5256194</comments>
            <pubDate>Wed, 21 Sep 2011 05:53:45 +0100</pubDate>
            <guid isPermaLink="false">5256194</guid>        </item>
        <item>
            <title>Federal state differentials in the efficiency of health production in Germany: an artifact of spatial dependence?</title>
            <link>http://www.medworm.com/index.php?rid=5216678&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc554018m85g72267%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Due to regional competition and patient migration, the efficiency of healthcare provision at the regional level is subject
 to spatial dependence. We address this issue by applying a spatial autoregressive model to longitudinal data from Germany
 at the district (‘Kreis’) level. The empirical model is specified to explain efficiency scores, which we derive through non-parametric
 order-m efficiency analysis of regional health production. The focus is on the role of health policy of federal states (‘Bundesländer’)
 for district efficiency. Regression results reveal significant spatial spillover effects. Notably, accounting for spatial
 dependence does not decrease but increases the estimated effect of federal states on district efficiency. It appears that
 genui...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5216678</comments>
            <pubDate>Thu, 08 Sep 2011 05:53:45 +0100</pubDate>
            <guid isPermaLink="false">5216678</guid>        </item>
        <item>
            <title>Key issues in the design of pay for performance programs</title>
            <link>http://www.medworm.com/index.php?rid=5194533&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl1022ju77l118t37%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Pay for performance (P4P) is increasingly being used to stimulate healthcare providers to improve their performance. However,
 evidence on P4P effectiveness remains inconclusive. Flaws in program design may have contributed to this limited success.
 Based on a synthesis of relevant theoretical and empirical literature, this paper discusses key issues in P4P-program design.
 The analysis reveals that designing a fair and effective program is a complex undertaking. The following tentative conclusions
 are made: (1) performance is ideally defined broadly, provided that the set of measures remains comprehensible, (2) concerns
 that P4P encourages “selection” and “teaching to the test” should not be dismissed, (3) sophisticated risk adjustment is important,
 especial...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5194533</comments>
            <pubDate>Thu, 01 Sep 2011 06:13:41 +0100</pubDate>
            <guid isPermaLink="false">5194533</guid>        </item>
        <item>
            <title>Budget impact analysis in economic evaluation: a proposal for a clearer definition</title>
            <link>http://www.medworm.com/index.php?rid=5173439&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F807760636643371v%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-4DOI 10.1007/s10198-011-0348-5Authors
		Livio Garattini, Department of Public Health, ‘Mario Negri’ Institute for Pharmacological Research, CESAV, Centre for Health Economics, Via Camozzi, 3 c/o Villa Camozzi, 24020 Ranica, Bergamo, ItalyKatelijne van de Vooren, Department of Public Health, ‘Mario Negri’ Institute for Pharmacological Research, CESAV, Centre for Health Economics, Via Camozzi, 3 c/o Villa Camozzi, 24020 Ranica, Bergamo, Italy
	

	
		Journal The European Journal of Health EconomicsOnline ISSN 1618-7601Print ISSN 1618-7598 (Source: The European Journal of Health Economics)</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5173439</comments>
            <pubDate>Sat, 27 Aug 2011 05:56:55 +0100</pubDate>
            <guid isPermaLink="false">5173439</guid>        </item>
        <item>
            <title>Balancing equity and efficiency in the Dutch basic benefits package using the principle of proportional shortfall</title>
            <link>http://www.medworm.com/index.php?rid=5173440&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh04gm415l6512743%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Economic evaluations are increasingly used to inform decisions regarding the allocation of scarce health care resources. To
 systematically incorporate societal preferences into these evaluations, quality-adjusted life year gains could be weighted
 according to some equity principle, the most suitable of which is a matter of frequent debate. While many countries still
 struggle with equity concerns for priority setting in health care, the Netherlands has reached a broad consensus to use the
 concept of proportional shortfall. Our study evaluates the concept and its support in the Dutch health care context. We discuss arguments in the Netherlands
 for using proportional shortfall and difficulties in transitioning from principle to practice. In doing so, we address univer...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5173440</comments>
            <pubDate>Fri, 26 Aug 2011 05:48:41 +0100</pubDate>
            <guid isPermaLink="false">5173440</guid>        </item>
        <item>
            <title>Loss of labour productivity caused by disease and health problems: what is the magnitude of its effect on Spain’s Economy?</title>
            <link>http://www.medworm.com/index.php?rid=5153575&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm473317687212080%2F</link>
            <description>This study underscores the strong economic impact of non-medical
 costs of diseases. In addition, it stresses the need for better information systems for collecting data that is relevant to
 the topic at hand.
 
 
	Content Type Journal ArticleCategory Original PaperPages 1-10DOI 10.1007/s10198-011-0344-9Authors
		Juan Oliva-Moreno, Facultad de Ciencias Jurídicas Y Sociales de Toledo, Análisis Económico Y Finanzas, Universidad de Castilla la Mancha, Cobertizo de San Pedro Mártir s/n, 45071 Toledo, Spain
	

	
		Journal The European Journal of Health EconomicsOnline ISSN 1618-7601Print ISSN 1618-7598 (Source: The European Journal of Health Economics)</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5153575</comments>
            <pubDate>Fri, 19 Aug 2011 15:53:11 +0100</pubDate>
            <guid isPermaLink="false">5153575</guid>        </item>
        <item>
            <title>A cost-effectiveness analysis of the Incredible Years parenting programme in reducing childhood health inequalities</title>
            <link>http://www.medworm.com/index.php?rid=5153576&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F93636u4106823532%2F</link>
            <description>This study forms the economic component
 of a randomised evaluation of the Incredible Years programme, a programme aimed at improving the skills and parenting strategies
 of parents of children with conduct problems. Our results show that the programme provides a cost-effective way of reducing
 behavioural problems. Furthermore, our cost analysis, when combined with a consideration of the potential long-run benefits,
 suggests that investment in such programmes may generate favourable long-run economic returns.
 
 
	Content Type Journal ArticleCategory Original PaperPages 1-10DOI 10.1007/s10198-011-0342-yAuthors
		Donal O’Neill, Department of Economics, NUI Maynooth, Ireland and Research Fellow IZA, Bonn, GermanySinéad McGilloway, Department of Psychology, NUI Maynooth, Maynooth, Irelan...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5153576</comments>
            <pubDate>Fri, 19 Aug 2011 06:41:19 +0100</pubDate>
            <guid isPermaLink="false">5153576</guid>        </item>
        <item>
            <title>Body weight and health-related quality of life in Catalonia, Spain</title>
            <link>http://www.medworm.com/index.php?rid=5153577&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg200p8544w237242%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Obesity poses important burdens not only on the individuals whose quality of life is reduced but on national welfare systems
 that have to face growing premature mortality rates, increase healthcare expenditures to treat obesity-related diseases, and
 earmark vast amounts of healthcare resources for prevention. The main goal of this paper is to analyze the relationship between
 excess body weight and different dimensions of health-related quality of life for people 16&amp;nbsp;years and older and to identify
 the health dimensions most affected by excess weight. We have drawn data from the Catalonia Health Survey (2006). Our results
 reveal a relationship between excess weight and health-related quality of life. Even after controlling for socio-economic
 status and objectiv...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5153577</comments>
            <pubDate>Fri, 19 Aug 2011 06:41:17 +0100</pubDate>
            <guid isPermaLink="false">5153577</guid>        </item>
        <item>
            <title>Smoking bans and the secondhand smoking problem: an economic analysis</title>
            <link>http://www.medworm.com/index.php?rid=5136827&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv45587g48211670k%2F</link>
            <description>This article investigates the role of partial smoking
 bans in coping with externalities caused by the secondhand smoking problem. Although it is widely known that Pigouvian taxation
 is superior to a perfect ban, this result does not necessarily carry over to a partial ban because taxes cannot (easily) be differentiated according to location. We show that under an easy and intuitive condition,
 (1) enacting a partial smoking ban alone always improves social welfare (a) in an unregulated society and (b) even in a regulated
 society if externalities can be eliminated, and (2) it is ensured that a combination of Pigouvian tax and a partial smoking
 ban leads to a higher social optimum than implementing corrective Pigouvian taxation alone.
 
 
	Content Type Journal ArticlePages 1-10DOI 10.100...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5136827</comments>
            <pubDate>Sat, 13 Aug 2011 06:12:08 +0100</pubDate>
            <guid isPermaLink="false">5136827</guid>        </item>
        <item>
            <title>Disease progression and costs of care in Alzheimer’s disease patients treated with donepezil: a longitudinal naturalistic cohort</title>
            <link>http://www.medworm.com/index.php?rid=5115681&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2n60np344178gh8p%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The proposed methods for representing AD progression and economic outcomes can be used in micro-simulation models for the
 economic evaluation of new treatments.
 
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s10198-011-0334-yAuthors
		Anders Gustavsson, i3 Innovus, Klarabergsviadukten 90 Hus D, 111 64 Stockholm, SwedenLinus Jönsson, i3 Innovus, Klarabergsviadukten 90 Hus D, 111 64 Stockholm, SwedenJohan Parmler, EPSI Rating, London, UKNiels Andreasen, Department of Neurobiology Caring Sciences and Society, Karolinska Institutet, Stockholm, SwedenCarina Wattmo, Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmö, SwedenÅsa K. Wallin, Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmö...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5115681</comments>
            <pubDate>Sat, 06 Aug 2011 05:54:22 +0100</pubDate>
            <guid isPermaLink="false">5115681</guid>        </item>
        <item>
            <title>The sustainability of European health care systems: beyond income and aging</title>
            <link>http://www.medworm.com/index.php?rid=5105676&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu254842v801q2496%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;During the last 30&amp;nbsp;years, health care expenditure (HCE) has been growing much more rapidly than GDP in OECD countries. In
 this paper, we review the determinants of HCE dynamics in Europe, taking into account the role of income, aging population,
 technological progress, female labor participation and public budgetary variables. We show that HCE is a multifaceted phenomenon
 where demographic, social, economic, technological and institutional factors all play an important role. The comparison of
 total, public and private HCE reveals an imbalance of European welfare toward the care of the elderly. European Governments
 should increasingly rely on pluralistic systems to balance sustainability and access and equilibrate the distribution of resources
 across the funct...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5105676</comments>
            <pubDate>Thu, 04 Aug 2011 15:33:46 +0100</pubDate>
            <guid isPermaLink="false">5105676</guid>        </item>
        <item>
            <title>Is health care a luxury or a necessity or both? Evidence from Turkey</title>
            <link>http://www.medworm.com/index.php?rid=5075123&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa340681775771108%2F</link>
            <description>This study investigates the effect of per capita income on per capita health expenditures in Turkey over the period 1975–2007
 by using ARDL bounds test approach to the cointegration considering both demand and supply side variables. Since we reject
 the null hypothesis that there is no cointegration among the series, we estimate long run and short run elasticities. The
 results show that while income has no effect on health expenditures in the long run, it is a necessity good in the short run
 that is a 1% increase in per capita income creates an 0.75% increase in per capita health expenditures. On the other hand,
 by examining the coefficient of demand and supply side variables, we found that average length of stay and number of physicians
 has negative effect, percentage of older peop...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5075123</comments>
            <pubDate>Wed, 27 Jul 2011 17:02:25 +0100</pubDate>
            <guid isPermaLink="false">5075123</guid>        </item>
        <item>
            <title>Measuring health outcomes of adolescents: report from a pilot study</title>
            <link>http://www.medworm.com/index.php?rid=5060948&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6545w88j26172162%2F</link>
            <description>This report explores the problems
 with the language and concepts embodied within those HRQoL questionnaires and open discussion regarding how we can value the
 health of adolescents for cost-utility analysis in a larger study.
 
 
	Content Type Journal ArticlePages 1-9DOI 10.1007/s10198-011-0340-0Authors
		Yemi Oluboyede, Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Charles Thackrah Building, Room 2.07, 101 Clarendon Road, Leeds, LS2 9LJ UKSandy Tubeuf, Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Charles Thackrah Building, Room 2.10, 101 Clarendon Road, Leeds, LS2 9LJ UKChris McCabe, Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Charles Thackrah Buil...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5060948</comments>
            <pubDate>Fri, 22 Jul 2011 17:02:02 +0100</pubDate>
            <guid isPermaLink="false">5060948</guid>        </item>
        <item>
            <title>Favourable cost-benefit in an early defibrillation programme using dual dispatch of ambulance and fire services in out-of-hospital cardiac arrest</title>
            <link>http://www.medworm.com/index.php?rid=5016086&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F186627547523623t%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The intervention of dual dispatch defibrillation by ambulance and fire services in the County of Stockholm had positive economic
 effects. For the cost-benefit analysis, the return on investment was high and the cost-effectiveness showed levels below the
 threshold value for economic efficiency used in Sweden. The cost-utility analysis categorises the cost per QALY as medium.
 
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s10198-011-0338-7Authors
		Björn Sund, Swedish Business School, Örebro University, 702 82 Örebro, SwedenLeif Svensson, Department of Cardiology, South Hospital, Karolinska Institute, Stockholm, SwedenMårten Rosenqvist, Department of Cardiology, South Hospital, Karolinska Institute, Stockholm, SwedenJacob Hollenberg, Department of Card...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5016086</comments>
            <pubDate>Fri, 08 Jul 2011 05:50:06 +0100</pubDate>
            <guid isPermaLink="false">5016086</guid>        </item>
        <item>
            <title>Cost effectiveness of golimumab for the treatment of active psoriatic arthritis</title>
            <link>http://www.medworm.com/index.php?rid=4996768&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk0727518p1213941%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Once monthly, golimumab is a cost-effective treatment alternative for patients with active PsA. With its patient-focussed
 attributes, golimumab is likely to offer additional choice in PsA treatment.
 
 
 
 
	Content Type Journal ArticlePages 1-9DOI 10.1007/s10198-011-0335-xAuthors
		Ewen Cummins, McMaster Development Consultants Ltd, Glasgow, UKChristian Asseburg, ESiOR Oy, Kuopio, FinlandManishi Prasad, Schering-Plough Ltd, Kenilworth, USAJacqueline Buchanan, Buchanan Biotech Consultants, Mountain View, CA, USAYogesh Suresh Punekar, Schering-Plough Ltd, Welwyn Garden City, AL7 1TW UK
	

	
		Journal The European Journal of Health EconomicsOnline ISSN 1618-7601Print ISSN 1618-7598 (Source: The European Journal of Health Economics)</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4996768</comments>
            <pubDate>Thu, 30 Jun 2011 17:49:56 +0100</pubDate>
            <guid isPermaLink="false">4996768</guid>        </item>
        <item>
            <title>Assessing preferences for improved smoking cessation medications: a discrete choice experiment</title>
            <link>http://www.medworm.com/index.php?rid=4973955&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh6p7203386417hg2%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;This study shows that there is a potential demand for improved cessation medications. Broader usage could be reached through
 lower out-of-pocket price and greater efficacy. Secondary aspects such as side effects and weight gain should also be taken
 into consideration.
 
 
 
 
	Content Type Journal ArticlePages 1-16DOI 10.1007/s10198-011-0333-zAuthors
		Joachim Marti, Faculty of Economics, Institute for Research in Economics, University of Neuchâtel, 2000 Neuchâtel, Switzerland
	

	
		Journal The European Journal of Health EconomicsOnline ISSN 1618-7601Print ISSN 1618-7598 (Source: The European Journal of Health Economics)</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4973955</comments>
            <pubDate>Sat, 25 Jun 2011 15:54:05 +0100</pubDate>
            <guid isPermaLink="false">4973955</guid>        </item>
        <item>
            <title>Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumab</title>
            <link>http://www.medworm.com/index.php?rid=4973957&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu5r222475k231224%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;When compared against capecitabine alone, the addition of lapatinib has a cost-effectiveness ratio exceeding the threshold
 normally used by NICE. Compared with T&amp;nbsp;+&amp;nbsp;C, L&amp;nbsp;+&amp;nbsp;C is dominant in the base case and approximately equally likely to be cost-effective
 in probabilistic sensitivity analyses over a wide range of threshold values.
 
 
 
 
	Content Type Journal ArticlePages 1-15DOI 10.1007/s10198-011-0323-1Authors
		Thomas E. Delea, Policy Analysis Inc. (PAI), Four Davis Court, Brookline, MA 02445, USAPaul Tappenden, School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UKOleg Sofrygin, Policy Analysis Inc. (PAI), Four Davis Court, Brookline, MA 02445, USADominy Browning, GlaxoSmithKline, London, UKMayur M. Amonkar, ...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4973957</comments>
            <pubDate>Fri, 24 Jun 2011 05:44:15 +0100</pubDate>
            <guid isPermaLink="false">4973957</guid>        </item>
        <item>
            <title>Pharmaceutical patents, R&amp;D incentives and access to new drugs: new ways of progress at the crossroad</title>
            <link>http://www.medworm.com/index.php?rid=4973956&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc6153744gv6307gl%2F</link>
            <description>Pharmaceutical patents, R&amp;D incentives and access to new drugs: new ways of progress at the crossroad
	Content Type Journal ArticlePages 1-3DOI 10.1007/s10198-011-0336-9Authors
		Fernando Antoñanzas, Department of Economics and Business, University of La Rioja, C/La Ciguena 60, 26004 Logrono, SpainCarmelo Juárez-Castelló, Department of Economics and Business, University of La Rioja, C/La Ciguena 60, 26004 Logrono, SpainRoberto Rodríguez-Ibeas, Department of Economics and Business, University of La Rioja, C/La Ciguena 60, 26004 Logrono, Spain
	

	
		Journal The European Journal of Health EconomicsOnline ISSN 1618-7601Print ISSN 1618-7598 (Source: The European Journal of Health Economics)</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4973956</comments>
            <pubDate>Fri, 24 Jun 2011 05:44:15 +0100</pubDate>
            <guid isPermaLink="false">4973956</guid>        </item>
        <item>
            <title>Patients whose GP knows complementary medicine tend to have lower costs and live longer</title>
            <link>http://www.medworm.com/index.php?rid=4966414&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj045w2v427006670%2F</link>
            <description>Discussion&amp;nbsp;&amp;nbsp;Since the differences are obtained while controlling for confounders including neighborhood specific fixed effects at a highly
 detailed level, the lower costs and longer lives are unlikely to be related to differences in socioeconomic status. Possible
 explanations include selection (e.g. people with a low taste for medical interventions might be more likely to choose CAM)
 and better practices (e.g. less overtreatment, more focus on preventive and curative health promotion) by GPs with knowledge
 of complementary medicine. More controlled studies (replication studies, research based on more comprehensive data, cost-effectiveness
 studies on CAM for specific diagnostic categories) are indicated.
 
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s10198-011-033...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4966414</comments>
            <pubDate>Wed, 22 Jun 2011 06:07:21 +0100</pubDate>
            <guid isPermaLink="false">4966414</guid>        </item>
        <item>
            <title>Paying informally in the Albanian health care sector: a two-tiered stochastic frontier model</title>
            <link>http://www.medworm.com/index.php?rid=4966415&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0772142211w56603%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Informal payments are deeply ingrained in the health care sector of most Central, Eastern and Southern European countries.
 Evidence suggests that the price paid informally to medical staff is negotiated either directly or indirectly between patients
 and medical staff. The aim of this paper is to measure the imperfect information that exists on the amount that has to be
 paid informally to medical staff. We measure the extent to which patients pay more than the amount medical staff expect informally
 and the extent to which medical staff request less than patients are willing to pay informally. A two-tiered stochastic frontier
 model is developed to estimate indicators of patients’ and medical staff’s imperfect information on informal payments and
 the effects on t...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4966415</comments>
            <pubDate>Tue, 21 Jun 2011 20:38:28 +0100</pubDate>
            <guid isPermaLink="false">4966415</guid>        </item>
        <item>
            <title>The cost-effectiveness of cash versus lottery incentives for a web-based, stated-preference community survey</title>
            <link>http://www.medworm.com/index.php?rid=4966416&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp37j278vp6082418%2F</link>
            <description>We present the results of a randomized experiment to test the effectiveness and cost-effectiveness of response incentives
 for a stated-preference survey of a general community population. The survey was administered using a mixed-mode approach,
 in which community members were invited to participate using a traditional mailed letter using contact information for a representative
 sample of the community; but individuals completed the survey via the web, which exploited the advantages of electronic capture.
 Individuals were randomized to four incentive groups: (a) no incentive, (b) prepaid cash incentive (2), (c) a low lottery (10 prizes of25) and (d) a high lottery (2 prizes of 250). Letters of invitation were mailed to 3,000 individuals. In total, 405 individuals (14.4 the highest conta...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4966416</comments>
            <pubDate>Tue, 21 Jun 2011 18:34:29 +0100</pubDate>
            <guid isPermaLink="false">4966416</guid>        </item>
        <item>
            <title>Economic evaluation of pay-for-performance in health care: a systematic review</title>
            <link>http://www.medworm.com/index.php?rid=4930642&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3814l4x3w3456l02%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The results show that evidence on the efficiency of P4P is scarce and inconclusive. P4P efficiency could not be demonstrated.
 The small number and variability of included studies limit the strength of our conclusions. More research addressing P4P efficiency
 is needed.
 
 
 
 
	Content Type Journal ArticlePages 1-13DOI 10.1007/s10198-011-0329-8Authors
		Martin Emmert, Chair of Health Business Administration, Institute of Management (IFM), School of Business and Economics, Friedrich-Alexander-University Erlangen-Nuremberg, Lange Gasse 20, 90403 Nuremberg, GermanyFrank Eijkenaar, Institute of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The NetherlandsHeike Kemter, Chair of Health Business Administration, Institute of Management (IFM), School ...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4930642</comments>
            <pubDate>Fri, 10 Jun 2011 06:29:39 +0100</pubDate>
            <guid isPermaLink="false">4930642</guid>        </item>
        <item>
            <title>Cancer patients’ willingness to pay for blood transfusions at home: results from a contingent valuation study in a French cancer network</title>
            <link>http://www.medworm.com/index.php?rid=4930641&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb02k7t59p0p5m670%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Home blood transfusion may be an interesting alternative to hospital transfusion, especially when given with curative or palliative
 intent or for terminal care in advanced-stage cancer patients. However, there is limited information about patients’ attitude
 toward this type of care. The purpose of this study was to measure French cancer patients’ willingness to pay (WTP) for home
 blood transfusion and to analyze determinants of their choice. A contingent valuation survey was administered to 139 patients
 receiving transfusions in the framework of a regional home care network or in the hospital outpatient department. Participation
 was high (90%). Most patients (65%) had received home care, including 43% blood transfusions. Just under half of the patients
 gave a ...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4930641</comments>
            <pubDate>Fri, 10 Jun 2011 06:29:39 +0100</pubDate>
            <guid isPermaLink="false">4930641</guid>        </item>
        <item>
            <title>Health care usage among immigrants and native-born elderly populations in eleven European countries: results from SHARE</title>
            <link>http://www.medworm.com/index.php?rid=4930644&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa3q0732817750271%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Differences in health care utilization of immigrants 50&amp;nbsp;years of age and older relative to the native-born populations in
 eleven European countries are investigated. Negative binomial and zero-inflated Poisson regression are used to examine differences
 between immigrants and native-borns in number of doctor visits, visits to general practitioners, and hospital stays using
 the 2004 Survey of Health, Ageing, and Retirement in Europe database. In the pooled European sample and in some individual
 countries, older immigrants use from 13 to 20% more health services than native-borns after demographic characteristics are
 controlled. After controlling for the need for health care, differences between immigrants and native-borns in the use of
 physicians, but not hospi...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4930644</comments>
            <pubDate>Fri, 10 Jun 2011 06:29:38 +0100</pubDate>
            <guid isPermaLink="false">4930644</guid>        </item>
        <item>
            <title>The use of cost per life year gained as a measurement of cost-effectiveness in Spain: a systematic review of recent publications</title>
            <link>http://www.medworm.com/index.php?rid=4930643&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj7v3l1q875032t2q%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;There is an increasing interest for economic health care evaluations in Spain, and the quality of the studies is also improving.
 Although a commonly accepted threshold exists, further information is needed for decision-making as well as to identify the
 relationship between the costs per LYG and per QALY gained.
 
 
 
 
	Content Type Journal ArticlePages 1-18DOI 10.1007/s10198-011-0326-yAuthors
		José Manuel Rodríguez Barrios, Medtronic Iberica, Madrid, SpainFerran Pérez Alcántara, Oblikue Consulting, S.L, C/Josep Irla i Bosch, 5-7, 1ª Planta, 08034 Barcelona, SpainCarlos Crespo Palomo, Oblikue Consulting, S.L, C/Josep Irla i Bosch, 5-7, 1ª Planta, 08034 Barcelona, SpainPaloma González García, Medtronic Iberica, Madrid, SpainEnrique Antón De Las Heras, Medt...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4930643</comments>
            <pubDate>Fri, 10 Jun 2011 06:29:38 +0100</pubDate>
            <guid isPermaLink="false">4930643</guid>        </item>
        <item>
            <title>Cost of care for colorectal cancer in Ireland: a health care payer perspective</title>
            <link>http://www.medworm.com/index.php?rid=4900200&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm131206g10t64x26%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;This study demonstrates the value of using existing data from national and local databases in contributing to estimating the
 cost of managing cancer. The findings illustrate the impact of biological agents on costs of cancer care and the potential
 of strategies promoting earlier diagnosis to reduce health care resource utilisation and care costs.
 
 
 
 
	Content Type Journal ArticlePages 1-14DOI 10.1007/s10198-011-0325-zAuthors
		L. Tilson, National Centre for Pharmacoeconomics, St James’s Hospital, Dublin 8, IrelandL. Sharp, National Cancer Registry Ireland, Cork Airport Business Park, Cork, IrelandC. Usher, National Centre for Pharmacoeconomics, St James’s Hospital, Dublin 8, IrelandC. Walsh, National Centre for Pharmacoeconomics, St James’s Hospital, Dubli...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4900200</comments>
            <pubDate>Fri, 03 Jun 2011 05:59:40 +0100</pubDate>
            <guid isPermaLink="false">4900200</guid>        </item>
        <item>
            <title>Informal caring-time and caregiver satisfaction</title>
            <link>http://www.medworm.com/index.php?rid=4900201&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fyq6901261x177j62%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;This paper examines the role of care decision processes on informal caring-time choices. We focus on three care decisions:
 the caregiver’s own decision, a family decision and a recipient request. Results show that informal caregivers, engaged in
 care activities as a result of a family decision, are more likely to devote more than 5&amp;nbsp;h to care activities, even after allowing
 for endogeneity. Our findings are robust to controlling for a large number of socio-demographic characteristics, including
 care recipient and caregiver characteristics. Supplemental analysis, developed to explore whether care arrangements are related
 to informal caregiver’s satisfaction, indicates that the family decision heavily penalizes informal caregivers. Given the
 importance of in...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4900201</comments>
            <pubDate>Thu, 02 Jun 2011 06:08:35 +0100</pubDate>
            <guid isPermaLink="false">4900201</guid>        </item>
        <item>
            <title>A proposed model for economic evaluations of major depressive disorder</title>
            <link>http://www.medworm.com/index.php?rid=4900202&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx138q4608043l572%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In countries like UK and Australia, the comparability of model-based analyses is an essential aspect of reimbursement decisions
 for new pharmaceuticals, medical services and technologies. Within disease areas, the use of models with alternative structures,
 type of modelling techniques and/or data sources for common parameters reduces the comparability of evaluations of alternative
 technologies for the same condition. The aim of this paper is to propose a decision analytic model to evaluate long-term costs
 and benefits of alternative management options in patients with depression. The structure of the proposed model is based on
 the natural history of depression and includes clinical events that are important from both clinical and economic perspectives.
 Considering...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4900202</comments>
            <pubDate>Thu, 02 Jun 2011 06:08:33 +0100</pubDate>
            <guid isPermaLink="false">4900202</guid>        </item>
        <item>
            <title>Measuring attitude toward social health insurance</title>
            <link>http://www.medworm.com/index.php?rid=4900203&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb7v7h72211u8777h%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In order to understand the health care system a country chooses to adopt or the health care reform a country decides to undertake,
 one must first be able to measure a country’s attitude toward social health insurance. Our primary goal was to develop a construct
 that allows us to measure this “attitude toward social health insurance”. Using a sample of 724 students from the People’s
 Republic of China, Germany, and the United States and an initial set of sixteen items, we extract a scale that measures the
 basic attitude toward social health insurance in the three countries. The scale is internally consistent in each of the three
 countries. A secondary factor labeled “government responsibility” is marginally consistent for the total sample and for the
 Ger...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4900203</comments>
            <pubDate>Wed, 01 Jun 2011 06:00:30 +0100</pubDate>
            <guid isPermaLink="false">4900203</guid>        </item>
        <item>
            <title>Genetic testing in the European Union: does economic evaluation matter?</title>
            <link>http://www.medworm.com/index.php?rid=4851695&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2892640432320287%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Economic evaluation of genetic technologies matters but the number of published studies is still rather low as to be widely
 used for most of the decisions in different jurisdictions across the EU. Further, the decision bodies across EU27 are fragmented
 and the responsibilities are located at different levels of the decision process for what it is difficult to find out whether
 a given decision on genetic tests was somehow supported by the economic evaluation results.
 
 
 
 
	Content Type Journal ArticlePages 1-11DOI 10.1007/s10198-011-0319-xAuthors
		Fernando Antoñanzas, Department of Economics, University of La Rioja, La Cigüeña 60, 26004 Logroño, SpainR. Rodríguez-Ibeas, Department of Economics, University of La Rioja, La Cigüeña 60, 26004 Logroño, Spain...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4851695</comments>
            <pubDate>Thu, 19 May 2011 16:36:45 +0100</pubDate>
            <guid isPermaLink="false">4851695</guid>        </item>
        <item>
            <title>The trade-off between formal and informal care in Spain</title>
            <link>http://www.medworm.com/index.php?rid=4851696&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fuq27r6q07104r050%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Understanding the factors that determine the type and amount of formal care is important for predicting use in the future
 and developing long-term policy. In this context, we jointly analyze the provision of care at both the extensive (choice of
 care) and the intensive margin (number of hours of care received). In particular, we estimate and test, for the first time
 in this area of research, a sample selection model with the particularities that the first step is a multinomial logit model
 and the hours of care is an interval variable. Our results support the complementary and task-specific models which evidence
 has been found in other countries. Furthermore, we obtain evidence of substitution between formal and informal care for the
 male, young, married and unmarr...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4851696</comments>
            <pubDate>Tue, 17 May 2011 06:15:14 +0100</pubDate>
            <guid isPermaLink="false">4851696</guid>        </item>
        <item>
            <title>What values do the public want their health care systems to use in evaluating technologies?</title>
            <link>http://www.medworm.com/index.php?rid=4838237&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fjttj45p21r013487%2F</link>
            <description>Content Type Journal ArticlePages 1-4DOI 10.1007/s10198-011-0320-4Authors
		Martin J. Buxton, Health Economics Research Group, Brunel University, Uxbridge, Middx, UB8 3PH UKJames D. Chambers, Health Economics Research Group, Brunel University, Uxbridge, Middx, UB8 3PH UK
	

	
		Journal The European Journal of Health EconomicsOnline ISSN 1618-7601Print ISSN 1618-7598 (Source: The European Journal of Health Economics)</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4838237</comments>
            <pubDate>Sat, 14 May 2011 15:54:46 +0100</pubDate>
            <guid isPermaLink="false">4838237</guid>        </item>
        <item>
            <title>The way that you do it? An elaborate test of procedural invariance of TTO, using a choice-based design</title>
            <link>http://www.medworm.com/index.php?rid=4838238&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F25352321213g7202%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The time tradeoff (TTO) method is often used to derive Quality-Adjusted Life Year health state valuations. An important problem
 with this method is that results have been found to be responsive to the procedure used to elicit preferences. In particular,
 fixing the duration in the health state to be valued and inferring the duration in full health that renders an individual
 indifferent, causes valuations to be higher than when the duration in full health is fixed and the duration in the health
 state to be valued is elicited. This paper presents a new test of procedural invariance for a broad range of time horizons,
 while using a choice-based design and adjusting for discounting. As one of the known problems with the conventional procedure
 is the violation of consta...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4838238</comments>
            <pubDate>Sat, 14 May 2011 15:54:45 +0100</pubDate>
            <guid isPermaLink="false">4838238</guid>        </item>
        <item>
            <title>The effect of health shocks on smoking and obesity</title>
            <link>http://www.medworm.com/index.php?rid=4818718&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn307t7352223421n%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The results of the study suggest that smokers are aware of the risks associated with tobacco consumption, know about effective
 strategies to quit smoking, and are willing to quit for health-related reasons. In contrast, there was no evidence for changes
 in health-related behaviour among obese individuals after a health shock.
 
 
 
 
	Content Type Journal ArticlePages 1-10DOI 10.1007/s10198-011-0316-0Authors
		Leonie Sundmacher, Department of Health Care Management, Berlin University of Technology, H80, Straße des 17. Juni 135, 10623 Berlin, Germany
	

	
		Journal The European Journal of Health EconomicsOnline ISSN 1618-7601Print ISSN 1618-7598 (Source: The European Journal of Health Economics)</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4818718</comments>
            <pubDate>Wed, 11 May 2011 06:25:53 +0100</pubDate>
            <guid isPermaLink="false">4818718</guid>        </item>
        <item>
            <title>On the meaningfulness of testing preference axioms in stated preference discrete choice experiments</title>
            <link>http://www.medworm.com/index.php?rid=4810998&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft233n4615n68q708%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A stream of studies on evaluation of health care services and public goods have developed tests of the preference axioms of
 completeness and transitivity and methods for detecting other preference phenomena such as unstability, learning- and tiredness
 effects, and random error, in stated preference discrete choice experiments. This methodological paper tries to identify the
 role of the preference axioms and other preference phenomena in the context of such experiments and discusses whether or how
 such axioms and phenomena can be subject to meaningful (statistical) tests.
 
 
	Content Type Journal ArticlePages 1-9DOI 10.1007/s10198-011-0312-4Authors
		Jens Leth Hougaard, Institute of Food and Resource Economics, University of Copenhagen, Copenhagen, DenmarkTue Tjur, ...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4810998</comments>
            <pubDate>Wed, 04 May 2011 14:55:46 +0100</pubDate>
            <guid isPermaLink="false">4810998</guid>        </item>
        <item>
            <title>Relative cost effectiveness of the SPHERE intervention in selected patient subgroups with existing coronary heart disease</title>
            <link>http://www.medworm.com/index.php?rid=4787201&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw08l4tq436233680%2F</link>
            <description>This study compares the cost effectiveness of a secondary prevention
 intervention for a combined patient population relative to three selected subgroups: patients aged over 70&amp;nbsp;years; patients
 with a diagnosis other than angina only (that is, patients with a history of myocardial infarction, coronary artery bypass
 graft and/or percutaneous transluminal coronary angioplasty); and patients with diabetes. The results for the general population
 have been published elsewhere, but ongoing budget constraints require consideration of the appropriateness of targeting resources
 to patient subgroups. We adopt a probabilistic model to combine within trial and beyond trial impacts of treatment to estimate
 the lifetime health care costs and quality-adjusted life years of two primary care-based...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4787201</comments>
            <pubDate>Mon, 02 May 2011 14:59:56 +0100</pubDate>
            <guid isPermaLink="false">4787201</guid>        </item>
        <item>
            <title>Cost–effectiveness of statins revisited: lessons learned about the value of innovation</title>
            <link>http://www.medworm.com/index.php?rid=4779073&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl1831201334u3qh5%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Only a small part of the surplus value generated was appropriated by the producer. A regulatory and reimbursement approach
 that favors early market access and coverage with evidence development as opposed to long-term trials as a pre-requisite for
 launch is more attractive from both a company and social perspective.
 
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s10198-011-0315-1Authors
		Peter Lindgren, Innovus, Stockholm, Sweden and Division of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Klarabergsviadukten 90 D, Stockholm, SwedenBengt Jönsson, Centre for Health Economics, Stockholm School of Economics, Stockholm, Sweden
	

	
		Journal The European Journal of Health EconomicsOnline ISSN 1618-7601Print ISSN 1...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4779073</comments>
            <pubDate>Fri, 29 Apr 2011 05:42:00 +0100</pubDate>
            <guid isPermaLink="false">4779073</guid>        </item>
        <item>
            <title>In with the new: the determinants of prescribing innovation by general practitioners in Ireland</title>
            <link>http://www.medworm.com/index.php?rid=4744523&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4464r861712103h7%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;An important element of the process by which new drugs achieve widespread use is their adoption by GPs. In this paper, we
 explore the factors that shape the timing of the first prescription of six new drugs by General Practitioners in Ireland.
 Our analysis is based on a dataset that matches prescription data with data on GP characteristics. We then use duration analysis
 to explore both equilibrium and non-equilibrium determinants of prescribing innovation. Our study highlights a range of commonalities
 across all of the drugs considered and suggests the importance of GP and practice characteristics in shaping prescribing decisions.
 We also find strongly significant, and consistently signed, stock and order effects across these drugs: GPs who have a track
 record of ...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4744523</comments>
            <pubDate>Tue, 19 Apr 2011 07:20:03 +0100</pubDate>
            <guid isPermaLink="false">4744523</guid>        </item>
        <item>
            <title>Factors determining access to and use of primary health care services in the Girona Health Region (Spain)</title>
            <link>http://www.medworm.com/index.php?rid=4744524&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm154127778543024%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;We do not detect any socioeconomic barriers associated with making a first contact with primary health services for the users
 analyzed. However, we do note evidence of horizontal inequity in terms of attending health services, related to variables
 that ought to affect use of health care as well as socioeconomic factors (variables that ought not to affect use of health
 care). The user’s origin is an important key in detecting different intensities of access and regular visits to primary health
 care services.
 
 
 
 
	Content Type Journal ArticlePages 1-9DOI 10.1007/s10198-011-0313-3Authors
		Carme Saurina, CIBER of Epidemiology and Public Health, University of Girona, Campus Montilivi, 17071 Girona, SpainLaura Vall-llosera, CIBER of Epidemiology and Public Healt...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4744524</comments>
            <pubDate>Sat, 16 Apr 2011 05:51:19 +0100</pubDate>
            <guid isPermaLink="false">4744524</guid>        </item>
        <item>
            <title>Cost-effectiveness of adjunctive eptifibatide in patients undergoing coronary stenting in Germany</title>
            <link>http://www.medworm.com/index.php?rid=4730870&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5l67kp06744h5274%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Eptifibatide is likely to be dominant strategy with 77.7 and 96.7% of the simulations leading to QALYs gained and generating
 cost savings from both the hospital and the third-party payer perspective. Eptifibatide offsets its additional treatment costs
 by avoiding costly repeat procedures and leads to positive QALY gains by preventing cardiovascular events lending themselves
 to transient or permanent lower quality of life. The method used to extrapolate the short-term risks did not impact on results,
 mainly due to similar clinical risk profiles between the two treatment groups in the long term.
 
 
 
 
	Content Type Journal ArticlePages 1-11DOI 10.1007/s10198-011-0310-6Authors
		Sarah Dewilde, Services in Health Economics, Rue des Eburons 55, 1000 Brussels, Belgiu...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4730870</comments>
            <pubDate>Tue, 12 Apr 2011 05:51:24 +0100</pubDate>
            <guid isPermaLink="false">4730870</guid>        </item>
        <item>
            <title>Cost-effectiveness of extended-release niacin/laropiprant added to a stable simvastatin dose in secondary prevention patients not at cholesterol goal in Germany</title>
            <link>http://www.medworm.com/index.php?rid=4691577&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F014p20017u050412%2F</link>
            <description>In conclusion, comprehensive lipid management with ERN/LRPT 2&amp;nbsp;g is cost-effective in secondary prevention patients in Germany
 who have not achieved LDL-C goal with simvastatin monotherapy.
 
 
	Content Type Journal ArticlePages 1-10DOI 10.1007/s10198-011-0309-zAuthors
		Galin V. Michailov, Outcomes Research Department, MSD Sharp &amp; Dohme GmbH, Haar, GermanyGlenn M. Davies, Health Economic Statistics, Merck &amp; Co. Inc., Upper Gwynedd, PA, USAKarl J. Krobot, Outcomes Research Department, MSD Sharp &amp; Dohme GmbH, Haar, Germany
	

	
		Journal The European Journal of Health EconomicsOnline ISSN 1618-7601Print ISSN 1618-7598 (Source: The European Journal of Health Economics)</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4691577</comments>
            <pubDate>Tue, 05 Apr 2011 10:04:48 +0100</pubDate>
            <guid isPermaLink="false">4691577</guid>        </item>
        <item>
            <title>Association of antipsychotic polypharmacy with health service cost: a register-based cost analysis</title>
            <link>http://www.medworm.com/index.php?rid=4675303&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff8113332775t203h%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The results demonstrate that antipsychotic co-prescribing is associated with increased use of health care services, even though
 no causal relations can be inferred from an observational study.
 
 
 
 
	Content Type Journal ArticlePages 1-9DOI 10.1007/s10198-011-0308-0Authors
		Lone Baandrup, Centre for Neuropsychiatric Schizophrenia Research, Copenhagen University Hospital, Mental Health Services - Capital Region of Denmark, Glostrup, Nordre Ringvej 29-67, 2600 Glostrup, DenmarkJan Sørensen, Centre for Applied Health Services Research and Technology Assessment, University of Southern Denmark, Odense, DenmarkHenrik Lublin, Centre for Neuropsychiatric Schizophrenia Research, Copenhagen University Hospital, Mental Health Services - Capital Region of Denmark, Glostrup, ...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4675303</comments>
            <pubDate>Thu, 31 Mar 2011 07:22:39 +0100</pubDate>
            <guid isPermaLink="false">4675303</guid>        </item>
        <item>
            <title>Lifetime costs of the top five cancers in Taiwan</title>
            <link>http://www.medworm.com/index.php?rid=4651109&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy188698277n2m2p0%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The purpose of this study was to determine cancer-related medical care costs for long-term cancer care costs of breast, cervical,
 liver, lung, and colorectal cancer. Data were sourced from Taipei Veterans General Hospital cancer registry and claim data
 during 1999–2002. Besides, claimed data from National Health Insurance were used to match the comparison group. To estimate
 lifetime cost (10&amp;nbsp;years), the whole disease process was divided into initial, continuing, and terminal three phases. The expected
 lifetime cost of a specific cancer patient was estimated by incorporating the average phase-specific costs with the survival
 rate and mortality rate. The undiscounted average lifetime costs (10&amp;nbsp;years) for lung cancer, colorectal cancer, liver cancer,
 cerv...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4651109</comments>
            <pubDate>Sun, 27 Mar 2011 05:54:57 +0100</pubDate>
            <guid isPermaLink="false">4651109</guid>        </item>
        <item>
            <title>Impact of healthcare reforms on out-of-pocket health expenditures in Turkey for public insurees</title>
            <link>http://www.medworm.com/index.php?rid=4620693&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl645228472004734%2F</link>
            <description>This study analyzes
 data on out-of-pocket (OOP) healthcare expenditures to look into the impact of reforms on the size of OOP health expenditures
 for premium-based public insurees. The study uses Household Budget Surveys that provide a range of individual- and household-level
 data as well as healthcare expenditures for the years 2003, before the reforms, and 2006, after the reforms. Results show
 that with the reforms ratio of households with non-zero OOP expenditure has increased. Share and level of OOP expenditures
 have decreased. The impact varies across income levels. A semi-parametric analysis shows that wealthier individuals benefited
 more in terms of the decrease in OOP health expenditures.
 
 
	Content Type Journal ArticlePages 1-10DOI 10.1007/s10198-011-0306-2Authors
		Burcay...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4620693</comments>
            <pubDate>Fri, 18 Mar 2011 16:47:45 +0100</pubDate>
            <guid isPermaLink="false">4620693</guid>        </item>
        <item>
            <title>Formal and informal care for disabled elderly living in the community: an appraisal of French care composition and costs</title>
            <link>http://www.medworm.com/index.php?rid=4589240&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fgn2006162584p756%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Public policies should pay more attention to inequalities in access to community care. They also should better support informal
 care, through respite care or workplace accommodations (working hours rescheduling or reduction for instance) not detrimental
 for the career of working caregivers.
 
 
 
 
	Content Type Journal ArticlePages 1-10DOI 10.1007/s10198-011-0305-3Authors
		Alain Paraponaris, INSERM, U912 (SE4S), 23 rue Stanislas Torrents, 13006 Marseille, FranceBérengère Davin, INSERM, U912 (SE4S), 23 rue Stanislas Torrents, 13006 Marseille, FrancePierre Verger, INSERM, U912 (SE4S), 23 rue Stanislas Torrents, 13006 Marseille, France
	

	
		Journal The European Journal of Health EconomicsOnline ISSN 1618-7601Print ISSN 1618-7598 (Source: The European Journal of H...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4589240</comments>
            <pubDate>Sat, 12 Mar 2011 16:52:49 +0100</pubDate>
            <guid isPermaLink="false">4589240</guid>        </item>
        <item>
            <title>Cost-effectiveness of treatment with etanercept for psoriasis in Sweden</title>
            <link>http://www.medworm.com/index.php?rid=4558419&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F404558222u142j24%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;This analysis showed that, with a 470,000&amp;nbsp;kr (&amp;#8364;50,000) per QALY willingness-to-pay threshold, once-weekly etanercept 50&amp;nbsp;mg,
 used intermittently, is a cost-effective treatment for moderate to severe psoriasis compared with adalimumab and non-systemic
 standard of care.
 
 
 
 
	Content Type Journal ArticlePages 1-12DOI 10.1007/s10198-010-0293-8Authors
		Christopher Knight, RTI Health Solutions, Velocity House Business and Conference Centre, 3 Solly Street, Sheffield, S1 4DE UKJosephine Mauskopf, RTI Health Solutions, 200 Park Offices Drive, Research Triangle Park, NC 27709-2194, USAMats Ekelund, Pfizer Inc., Solna, SwedenAmitabh Singh, Pfizer Inc., 500 Arcola Road, Collegeville, PA 19426, USAShiyi Yang, Pfizer Inc., 500 Arcola Road, Collegeville, PA 1...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4558419</comments>
            <pubDate>Sat, 05 Mar 2011 16:52:10 +0100</pubDate>
            <guid isPermaLink="false">4558419</guid>        </item>
        <item>
            <title>Defining care products to finance health care in the Netherlands</title>
            <link>http://www.medworm.com/index.php?rid=4539608&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa406302m67116290%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A case-mix project started in the Netherlands with the primary goal to define a complete set of health care products for hospitals.
 The definition of the product structure was completed 4&amp;nbsp;years later. The results are currently being used for billing purposes.
 This paper focuses on the methodology and techniques that were developed and applied in order to define the casemix product
 structure. The central research question was how to develop a manageable product structure, i.e., a limited set of hospital
 products, with acceptable cost homogeneity. For this purpose, a data warehouse with approximately 1.5 million patient records
 from 27 hospitals was build up over a period of 3&amp;nbsp;years. The data associated with each patient consist of a large number of
 a prio...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4539608</comments>
            <pubDate>Thu, 24 Feb 2011 17:34:18 +0100</pubDate>
            <guid isPermaLink="false">4539608</guid>        </item>
        <item>
            <title>Socioeconomic analysis of patient-centric networks: effects of patients and hospitals’ characteristics and network structure on hospitalization costs</title>
            <link>http://www.medworm.com/index.php?rid=4539609&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe23588102g2wj6l8%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Improving operations and delivery of cost-effective healthcare services is considered to be an important area of investigation
 due to the challenges in allocation of resources in meeting the increasing cost of health care for the twenty-first century.
 To date, appropriate mechanisms for systematic evaluation of hospital operations and its impact of the delivery of cost-effective
 healthcare services are lacking. This is, perhaps, the first study, which focuses on using large insurance claims data to
 develop a social network-based model for exploring the effect of patient–doctor tie strength and patient socio-demographic
 factors for exploring the social structure of operations and delivery of cost-effective healthcare services. We suggest that
 delivery of cost-eff...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4539609</comments>
            <pubDate>Thu, 24 Feb 2011 07:14:25 +0100</pubDate>
            <guid isPermaLink="false">4539609</guid>        </item>
        <item>
            <title>The demand for sports and exercise: results from an illustrative survey</title>
            <link>http://www.medworm.com/index.php?rid=4520968&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fuu528l4125684220%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;There is a paucity of empirical evidence on the extent to which price and perceived benefits affect the level of participation
 in sports and exercise. Using an illustrative sample of 60 adults at Brunel University, West London, we investigate the determinants
 of demand for sports and exercise. The data were collected through face-to-face interviews that covered indicators of sports
 and exercise behaviour; money/time price and perceived benefits of participation; and socio-economic/demographic details.
 Count, linear and probit regression models were fitted as appropriate. Seventy eight per cent of the sample participated in
 sports and exercise and spent an average of £27 per month and an average of 20&amp;nbsp;min travelling per occasion of sports and exercise.
 The de...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4520968</comments>
            <pubDate>Tue, 22 Feb 2011 17:04:52 +0100</pubDate>
            <guid isPermaLink="false">4520968</guid>        </item>
        <item>
            <title>I feel good! Gender differences and reporting heterogeneity in self-assessed health</title>
            <link>http://www.medworm.com/index.php?rid=4463396&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F317316w380x36470%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;For empirical analysis and policy-oriented recommendations, the precise measurement of individual health or well-being is
 essential. The difficulty is that the answer may depend on individual reporting behaviour. Moreover, if an individual’s health
 perception varies with certain attitudes of the respondent, reporting heterogeneity may lead to index or cut-point shifts
 of the health distribution, causing estimation problems. An index shift is a parallel shift in the thresholds of the underlying
 distribution of health categories. In contrast, a cut-point shift means that the relative position of the thresholds changes,
 implying different response behaviour. Our paper aims to detect how socioeconomic determinants and health experiences influence
 the individual valu...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4463396</comments>
            <pubDate>Tue, 08 Feb 2011 21:23:01 +0100</pubDate>
            <guid isPermaLink="false">4463396</guid>        </item>
        <item>
            <title>Incremental net benefit and acceptability of alternative health policies: a case study of mass screening for colorectal cancer</title>
            <link>http://www.medworm.com/index.php?rid=4463397&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ftg265734564549n7%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The incremental net benefit (INB) and the related acceptability curves for public health programs provide valuable tools for
 decision making. We proposed to apply them to the assessment of mass screening of colorectal cancer. The now standard guaiac
 fecal occult blood test (FOBT) is already implemented in several countries. We considered the innovative immunological FOBT
 and computed tomography colonography (CTC) as competing screening technologies. Using biennial guaiac FOBT as the reference
 strategy, we estimated the cost-effectiveness of the following alternatives: biennial immunological FOBT, CTC every 5&amp;nbsp;years
 (strategy CTC5), and CTC every 10&amp;nbsp;years (strategy CTC10). Over a 30-year horizon and from the perspective of a third-party
 payer, we developed...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4463397</comments>
            <pubDate>Tue, 08 Feb 2011 21:23:00 +0100</pubDate>
            <guid isPermaLink="false">4463397</guid>        </item>
        <item>
            <title>Exploring the disparities of regional health care expenditures in Switzerland: some empirical evidence</title>
            <link>http://www.medworm.com/index.php?rid=4441562&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk735n4w485400521%2F</link>
            <description>This study investigates the determinants of regional variations in health care expenditures (HCE) in Switzerland, since there
 are significant differences between cantons per capita HCE. The empirical analysis contributes to the discussion on the outcome
 of federalism in the Swiss health care system by improving the understanding of the determinants of the differences in HCE.
 Our econometric estimations indicate that HCE are significantly related to the density of specialist physicians, density of
 dispensing doctors, per capita income, proportion of managed care, medical and technological progress and socio-economic factors.
 Due to the presumptive importance of the organisation of ambulatory care, we suggest policy makers should particularly concentrate
 on promoting the supply of mana...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4441562</comments>
            <pubDate>Thu, 03 Feb 2011 20:57:37 +0100</pubDate>
            <guid isPermaLink="false">4441562</guid>        </item>
        <item>
            <title>Relative effectiveness and the European pharmaceutical market</title>
            <link>http://www.medworm.com/index.php?rid=4417991&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr06t4323rg427g02%2F</link>
            <description>Content Type Journal ArticlePages 1-6DOI 10.1007/s10198-011-0297-zAuthors
		Bengt Jönsson, Stockholm School of Economics, Stockholm, Sweden
	

	
		Journal The European Journal of Health EconomicsOnline ISSN 1618-7601Print ISSN 1618-7598 (Source: The European Journal of Health Economics)</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4417991</comments>
            <pubDate>Wed, 26 Jan 2011 19:46:26 +0100</pubDate>
            <guid isPermaLink="false">4417991</guid>        </item>
        <item>
            <title>To model or not to model: lessons from two vaccinations</title>
            <link>http://www.medworm.com/index.php?rid=4410528&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6615101wv4311052%2F</link>
            <description>Content Type Journal ArticlePages 1-3DOI 10.1007/s10198-011-0298-yAuthors
		Livio Garattini, CESAV, Centre of Health Economics, Via Camozzi, 3 c/o Villa Camozzi, 24020 Ranica (Bergamo), ItalyAnna Padula, CESAV, Centre of Health Economics, Via Camozzi, 3 c/o Villa Camozzi, 24020 Ranica (Bergamo), Italy
	

	
		Journal The European Journal of Health EconomicsOnline ISSN 1618-7601Print ISSN 1618-7598 (Source: The European Journal of Health Economics)</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4410528</comments>
            <pubDate>Tue, 25 Jan 2011 23:15:47 +0100</pubDate>
            <guid isPermaLink="false">4410528</guid>        </item>
        <item>
            <title>Treating pneumonia in critical care in the United Kingdom following failure of initial antibiotic: a cost-utility analysis comparing meropenem with piperacillin/tazobactam</title>
            <link>http://www.medworm.com/index.php?rid=4376453&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq044j5t32601vt4l%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The additional efficacy of meropenem translates into more patients surviving critical care and leaving this high-cost service
 more quickly than if they had been treated with piperacillin/tazobactam. As meropenem is more effective and less expensive
 than piperacillin/tazobactam at treating patients with severe pneumonia, it is the dominant treatment option.
 
 
 
 
	Content Type Journal ArticlePages 1-12DOI 10.1007/s10198-011-0296-0Authors
		Steven J. Edwards, Kellogg College, University of Oxford, 62 Banbury Road, Oxford, OX2 6PN UKSarah Wordsworth, Health Economics Research Centre, Department of Public Health, University of Oxford, Oxford, UKMike J. Clarke, UK Cochrane Centre, National Institute for Health Research, Oxford, UK
	

	
		Journal The European Journal of...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4376453</comments>
            <pubDate>Tue, 18 Jan 2011 15:05:14 +0100</pubDate>
            <guid isPermaLink="false">4376453</guid>        </item>
        <item>
            <title>Malpractice liability, technology choice and negative defensive medicine</title>
            <link>http://www.medworm.com/index.php?rid=4341810&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft4664647r5458773%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We extend the theoretical literature on the impact of malpractice liability by allowing for two treatment technologies, a
 safe and a risky one. The safe technology bears no failure risk, but leads to patient-specific disutility since it cannot completely solve
 the health problems. By contrast, the risky technology (for instance a surgery) may entirely cure patients, but fail with
 some probability depending on the hospital’s care level. Tight malpractice liability increases care levels if the risky technology
 is chosen at all, but also leads to excessively high incentives for avoiding the liability exposure by adopting the safe technology.
 We refer to this distortion toward the safe technology as negative defensive medicine. Taking the problem of negative defensiv...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4341810</comments>
            <pubDate>Mon, 10 Jan 2011 16:11:41 +0100</pubDate>
            <guid isPermaLink="false">4341810</guid>        </item>
        <item>
            <title>Decision-making in general practice: the effect of financial incentives on the use of laboratory analyses</title>
            <link>http://www.medworm.com/index.php?rid=4326704&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F77567g4480811738%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;This paper examines the reaction of general practitioners (GPs) to a reform in 2004 in the remuneration system for using laboratory
 services in general practice. The purpose of this paper is to study whether income motivation exists regarding the use of
 laboratory services in general practice, and if so, the degree of income motivation among general practitioners (GPs) in Norway.
 We argue that the degree of income motivation is stronger when the physicians are uncertain about the utility of the laboratory
 service in question. We have panel data from actual physician–patient encounters in general practices in the years 2001–2004
 and use discrete choice analysis and random effects models. Estimation results show that an increase in the fees will lead
 to a small ...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4326704</comments>
            <pubDate>Thu, 06 Jan 2011 17:54:14 +0100</pubDate>
            <guid isPermaLink="false">4326704</guid>        </item>
        <item>
            <title>Towards a social discount rate for the economic evaluation of health technologies in Germany: an exploratory analysis</title>
            <link>http://www.medworm.com/index.php?rid=4280228&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl22605883307210p%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Over the last decades, methods for the economic evaluation of health care technologies were increasingly used to inform reimbursement
 decisions. For a short time, the German Statutory Health Insurance makes use of these methods to support reimbursement decisions
 on patented drugs. In this context, the discounting procedure emerges as a critical component of these methods, as discount
 rates can strongly affect the resulting incremental cost-effectiveness ratios. The aim of this paper is to identify the appropriate
 value of a social discount rate to be used by the German Statutory Health Insurance for the economic evaluation of health
 technologies. On theoretical grounds, we build on the widespread view of contemporary economists that the social rate of time
 prefere...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4280228</comments>
            <pubDate>Mon, 20 Dec 2010 15:20:09 +0100</pubDate>
            <guid isPermaLink="false">4280228</guid>        </item>
        <item>
            <title>Cost-effectiveness model for a specific mixture of prebiotics in The Netherlands</title>
            <link>http://www.medworm.com/index.php?rid=4274460&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8672183w85r8537m%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;This study shows that the favourable health benefit of the use of a specific mixture of prebiotics results in positive short-
 and long-term health economic benefits. In addition, this study demonstrates that the use of infant formula with a specific
 mixture of prebiotics is a highly cost-effective way of preventing atopic dermatitis in The Netherlands.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s10198-010-0289-4Authors
		I. Lenoir-Wijnkoop, Scientific Affairs, Danone Research, Palaiseau, FranceW. M. C. van Aalderen, Department of Pediatric Respiratory Medicine and Allergy, Emma Children’s Hospital Academic Medical Center, Amsterdam, The NetherlandsG. Boehm, Centre for Specialised Nutrition, Danone Research, Friedrichsdorf, GermanyD. Klaassen, Centre for Spec...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4274460</comments>
            <pubDate>Thu, 16 Dec 2010 18:25:12 +0100</pubDate>
            <guid isPermaLink="false">4274460</guid>        </item>
        <item>
            <title>Letter from the editors</title>
            <link>http://www.medworm.com/index.php?rid=4270737&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj665776705n1000r%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s10198-010-0291-xAuthors
		J.-Matthias Graf von der Schulenburg, Department for Health Economics, University of Bielefeld, Bielefeld, GermanyWolfgang Greiner, Department for Health Economics, University of Bielefeld, Bielefeld, Germany
	

	
		Journal The European Journal of Health EconomicsOnline ISSN 1618-7601Print ISSN 1618-7598 (Source: The European Journal of Health Economics)</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4270737</comments>
            <pubDate>Tue, 14 Dec 2010 06:40:04 +0100</pubDate>
            <guid isPermaLink="false">4270737</guid>        </item>
        <item>
            <title>Trust on doctor, social capital and medical care use of the elderly</title>
            <link>http://www.medworm.com/index.php?rid=4240718&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh040pl3132l2422l%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Using data from a survey sample of people 65&amp;nbsp;years of age and older living in Seoul and Chuncheon, Korea, this paper assesses
 whether the level of social capital affects elderly individuals’ use of medical care. As an econometric model, Heckman’s Sample
 Selection model and the 2SLS method were used to control the endogeneity problem of patient’s trust on doctors. The results
 of our estimations indicate that the level of social capital exerts a positive effect on elderly individuals’ use of medical
 care indirectly, via its positive effect on the level of trust in doctors.
 
 
	Content Type Journal ArticleDOI 10.1007/s10198-010-0288-5Authors
		Jae-Young Lim, Department of Food and Resource Economics, College of Life Science, Korea University, Seoul, Korea...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4240718</comments>
            <pubDate>Mon, 06 Dec 2010 15:06:58 +0100</pubDate>
            <guid isPermaLink="false">4240718</guid>        </item>
        <item>
            <title>Comparing the sensitivity of EQ-5D, SF-6D and 15D utilities to the specific effect of diabetic complications</title>
            <link>http://www.medworm.com/index.php?rid=4240717&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr84502216l862564%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;After removing the effect of background variables, 15D utilities remain sensitive to CHD and DR. The obvious explanation is
 its richer descriptive system, which provides increased discriminative ability compared to EQ-5D and SF-6D, and this might
 be evidence for preferring the 15D in economic evaluations of interventions for diabetics. However, the need remains for further
 testing in other diabetes complications and more diverse patient samples.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s10198-010-0290-yAuthors
		Nick Kontodimopoulos, Faculty of Social Sciences, Hellenic Open University, Bouboulinas 57-59, 26222 Patras, GreeceEvelina Pappa, Faculty of Social Sciences, Hellenic Open University, Bouboulinas 57-59, 26222 Patras, GreeceZinovia Chadjiapostolou, ...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4240717</comments>
            <pubDate>Mon, 06 Dec 2010 15:06:58 +0100</pubDate>
            <guid isPermaLink="false">4240717</guid>        </item>
        <item>
            <title>Do smoke-free laws affect revenues in pubs and restaurants?</title>
            <link>http://www.medworm.com/index.php?rid=4188775&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw77330120051x612%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In the debate about laws regulating smoking in restaurants and pubs, there has been some controversy as to whether smoke-free
 laws would reduce revenues in the hospitality industry. Norway presents an interesting case for three reasons. First, it was
 among the first countries to implement smoke-free laws, so it is possible to assess the long-term effects. Second, it has
 a cold climate so if there is a negative effect on revenue one would expect to find it in Norway. Third, the data from Norway
 are detailed enough to distinguish between revenue from pubs and restaurants. Autoregressive integrated moving average (ARIMA)
 intervention analysis of bi-monthly observations of revenues in restaurants and pubs show that the law did not have a statistically
 significant long...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4188775</comments>
            <pubDate>Fri, 19 Nov 2010 17:01:57 +0100</pubDate>
            <guid isPermaLink="false">4188775</guid>        </item>
        <item>
            <title>Pharmacoeconomic evaluation of tiotropium bromide in the long-term treatment of chronic obstructive pulmonary disease (COPD) in Italy</title>
            <link>http://www.medworm.com/index.php?rid=4188776&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe42q17803q5v8362%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The randomized, double-blind trial UPLIFT® demonstrated in 5,993 patients with moderate to very severe COPD that 4&amp;nbsp;years of tiotropium bromide therapy were associated
 with improvements in lung function, exacerbations, quality of life, and mortality compared with placebo. The pharmacoeconomic
 evaluation was performed through a probabilistic, patient-level simulation Markov model. Routine COPD care (RC) was compared
 with the inclusion of tiotropium bromide on it. The analysis was conducted over a lifetime horizon, with 1&amp;nbsp;year cycles and
 a 3.5% annual discount rate. Patients were characterized by gender, age, height, smoking status, and forced expiratory volume
 in 1&amp;nbsp;s (FEV1). FEV1 time trend was modeled according to the annual decline recorded in UPLIF...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4188776</comments>
            <pubDate>Wed, 17 Nov 2010 21:04:42 +0100</pubDate>
            <guid isPermaLink="false">4188776</guid>        </item>
        <item>
            <title>The cost of multiple sclerosis in Norway</title>
            <link>http://www.medworm.com/index.php?rid=4181865&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7918353290636711%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Health economic aspects have been increasingly important during introduction of new treatments for multiple sclerosis. As
 a partial response for Norway, a cost-of-illness study was carried out to estimate the yearly cost of the illness to society
 and relate costs and patients’ quality of life to illness severity. Estimated cost to society was Euro 439 million in 2002
 exclusive of the cost of reduced quality of life. The cost per patient was close to Euro 65,000. Account taken of methodological
 differences, the results compare to results for Sweden, Norway’s closest neighboring country. The illness reduced patients’
 quality of life with 0.26. More patients were early retired because of their MS in Norway than in any of nine other European
 countries comprised ...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4181865</comments>
            <pubDate>Tue, 16 Nov 2010 07:09:44 +0100</pubDate>
            <guid isPermaLink="false">4181865</guid>        </item>
        <item>
            <title>A French approach to cost-effectiveness analysis?</title>
            <link>http://www.medworm.com/index.php?rid=4131301&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm77lu70711l72223%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s10198-010-0284-9Authors
		Gérard de Pouvourville, ESSEC Business School, 95021 Cergy Pontoise Cedex, France
	

	
		Journal The European Journal of Health EconomicsOnline ISSN 1618-7601Print ISSN 1618-7598 (Source: The European Journal of Health Economics)</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4131301</comments>
            <pubDate>Tue, 02 Nov 2010 17:21:06 +0100</pubDate>
            <guid isPermaLink="false">4131301</guid>        </item>
        <item>
            <title>Health care costs and their predictors of inflammatory bowel diseases in Germany</title>
            <link>http://www.medworm.com/index.php?rid=4094539&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fct54257682103244%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;This is the first study to calculate costs due to CD and UC from the perspective of the SHI in Germany and to identify cost-driving
 factors. It confirms a high economic burden of IBD to payers and society.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s10198-010-0281-zAuthors
		Anne Prenzler, Leibniz University Hannover, Center for Health Economics, Koenigsworther Platz 1, 30167 Hannover, GermanyBernd Bokemeyer, Gastroenterology Practice Minden, Minden, GermanyJ.-Matthias von der Schulenburg, Leibniz University Hannover, Center for Health Economics, Koenigsworther Platz 1, 30167 Hannover, GermanyThomas Mittendorf, Leibniz University Hannover, Center for Health Economics, Koenigsworther Platz 1, 30167 Hannover, Germany
	

	
		Journal The European Journal of Health...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4094539</comments>
            <pubDate>Thu, 21 Oct 2010 17:15:43 +0100</pubDate>
            <guid isPermaLink="false">4094539</guid>        </item>
        <item>
            <title>Cost-effectiveness analysis, welfare economics, and the societal perspective: a reply</title>
            <link>http://www.medworm.com/index.php?rid=4094540&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw0g4m138upq51171%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A critical question in cost-effectiveness analysis (CEA) is what costs should be included. In an earlier paper in this journal,
 I argued that the same principle (internal consistency) that has been applied to the discussion about future non-medical costs
 should also be applied to the case when survival is not affected. Internal consistency in this case implies that a cost should
 only be included if its corresponding utility is also included. As Quality-Adjusted Life-Years can rarely be considered to
 be consistent with a broad definition of utility, I built a case for recommending to not including the costs for changes in
 consumption and absence from work (whereas changes in the productivity at work may still be included) when applying a welfare
 theoretic foundatio...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4094540</comments>
            <pubDate>Tue, 19 Oct 2010 19:30:35 +0100</pubDate>
            <guid isPermaLink="false">4094540</guid>        </item>
        <item>
            <title>On the welfare theoretic foundation of CEA: comment</title>
            <link>http://www.medworm.com/index.php?rid=4084939&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fmw143253ujpk1215%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;This is a comment on a recent paper by Bengt Liljas (Eur J Health Econ 11:5–13, 2010) in this Journal. The author’s analysis
 is flawed because he fails to take the envelope theorem into account. As a bottom line, we conclude that from a welfare theoretic
 point of view, future consumption and future labor hours should not be considered in a valid CEA.
 
 
	Content Type Journal ArticleDOI 10.1007/s10198-010-0282-yAuthors
		Friedrich Breyer, Department of Economics, University of Konstanz, Fach 135, 78457 Constance, Germany
	

	
		Journal The European Journal of Health EconomicsOnline ISSN 1618-7601Print ISSN 1618-7598 (Source: The European Journal of Health Economics)</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4084939</comments>
            <pubDate>Fri, 15 Oct 2010 21:09:13 +0100</pubDate>
            <guid isPermaLink="false">4084939</guid>        </item>
        <item>
            <title>The impact of BMI on direct costs in Children and Adolescents: empirical findings for the German Healthcare System based on the KiGGS-study</title>
            <link>http://www.medworm.com/index.php?rid=4021535&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa208764t20343244%2F</link>
            <description>Discussion&amp;nbsp;&amp;nbsp;The economic implications of overweight and obesity are, to some extent, already visible in childhood. The results suggest
 that obese children should be classified as priority group for prevention. Despite limitations, this study provides important
 information concerning the relevance of childhood obesity as a health problem.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s10198-010-0278-7Authors
		Christina M. Wenig, Ludwig-Maximilians-Universität München, Munich School of Management, Institute of Health Economics and Health Care Management and Munich Centre of Health Sciences, Ludwigstr. 28 RG, 80539 Munich, Germany
	

	
		Journal The European Journal of Health EconomicsOnline ISSN 1618-7601Print ISSN 1618-7598 (Source: The European Journal of Health Economics...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4021535</comments>
            <pubDate>Wed, 29 Sep 2010 05:45:04 +0100</pubDate>
            <guid isPermaLink="false">4021535</guid>        </item>
        <item>
            <title>Future costs in cost-effectiveness analysis: an empirical assessment</title>
            <link>http://www.medworm.com/index.php?rid=4010354&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb75n48g477781m5g%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;This paper contains cost figures for use in cost-effectiveness analyses, when the societal perspective is adopted and future
 consumption and production effects are taken into account. The net consumption varies considerably with age. Inclusion of
 net incremental consumption in the cost-effectiveness analysis will markedly affect the relative cost-effectiveness of interventions
 targeted at different age groups. Omitting future cost from cost-effectiveness analysis may bias the ranking of health care
 interventions and favour interventions aimed at older age groups. We used Danish data for this assessment, and our results
 will therefore not represent true figures for other countries. We do, however, believe that the overall impact of including
 net production value ...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4010354</comments>
            <pubDate>Mon, 27 Sep 2010 16:50:00 +0100</pubDate>
            <guid isPermaLink="false">4010354</guid>        </item>
        <item>
            <title>Spillover effects of supplementary on basic health insurance: evidence from the Netherlands</title>
            <link>http://www.medworm.com/index.php?rid=4000814&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F76p520802q680702%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Like many other countries, the Netherlands has a health insurance system that combines mandatory basic insurance with voluntary
 supplementary insurance. Both types of insurance are founded on different principles. Since basic and supplementary insurance
 are sold by the same health insurers, both markets may interact. This paper examines to what extent basic and supplementary
 insurance are linked to each other and whether these links generate spillover effects of supplementary on basic insurance.
 Our analysis is based on an investigation into supplementary health insurance contracts, underwriting procedures and annual
 surveys among 1,700–2,100 respondents over the period 2006–2009. We find that health insurers increasingly use a variety of
 strategies to enforce...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4000814</comments>
            <pubDate>Thu, 23 Sep 2010 05:46:24 +0100</pubDate>
            <guid isPermaLink="false">4000814</guid>        </item>
        <item>
            <title>Decomposing the determinants of health care expenditure: the case of Spain</title>
            <link>http://www.medworm.com/index.php?rid=3991800&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc2706446725q277u%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The aim of this paper is to analyze the determinants of regional health-care expenditure in Spain. The coexistence of several
 models concerning the degree of spending power decentralization and financing systems makes Spain a singular case. It also
 allows us to draw conclusions relevant to other countries
 in decentralizing their health-care systems, and to understand cross-country differences with estimated parameters. Using
 data from the Spanish regions for the period 1992–2005, we show that the estimated health public expenditure income elasticity
 does change depending on the omission of relevant variables,
 econometric specifications and techniques, and institutional arrangements. Moreover, while demographic structure is a very
 relevant factor when explaining...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3991800</comments>
            <pubDate>Sat, 18 Sep 2010 16:59:03 +0100</pubDate>
            <guid isPermaLink="false">3991800</guid>        </item>
        <item>
            <title>Market structure and hospital–insurer bargaining in the Netherlands</title>
            <link>http://www.medworm.com/index.php?rid=3991801&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F477hx26326t61467%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In 2005, competition was introduced in part of the hospital market in the Netherlands. Using a unique dataset of transactions
 and list prices between hospitals and insurers in the years 2005 and 2006, we estimate the influence of buyer and seller concentration
 on the negotiated prices. First, we use a traditional structure–conduct–performance model (SCP-model) along the lines of Melnick
 et al. (J Health Econ 11(3): 217–233, 1992) to estimate the effects of buyer and seller concentration on price–cost margins.
 Second, we model the interaction between hospitals and insurers in the context of a generalized bargaining model similar to
 Brooks et al. (J Health Econ 16: 417–434, 1997). In the SCP-model, we find that the market shares of hospitals (insurers)
 hav...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3991801</comments>
            <pubDate>Sat, 18 Sep 2010 16:59:02 +0100</pubDate>
            <guid isPermaLink="false">3991801</guid>        </item>
        <item>
            <title>The impact of presumed consent laws and institutions on deceased organ donation</title>
            <link>http://www.medworm.com/index.php?rid=3981791&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F683k524r00426n16%2F</link>
            <description>This article purports to advance the literature on the impact of presumed consent laws on deceased donation rates by examining
 the interactions between a presumed consent legal regime and other customs and institutions, using data on health expenditure,
 death rates caused by cerebro vascular diseases, motor vehicle accidents and homicides, legislation, legal systems, family
 consent, civil rights and liberties and donor registry systems, for 24 countries over a 14-year period. Countries in which
 presumed consent is enacted exhibit significantly higher donation rates only if family consent is routinely sought and a combined
 registry is maintained or neither practice is administered. Otherwise, presumed consent legislation does not have a sizeable
 impact on deceased donation rates.
 
 
...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3981791</comments>
            <pubDate>Fri, 17 Sep 2010 06:45:03 +0100</pubDate>
            <guid isPermaLink="false">3981791</guid>        </item>
        <item>
            <title>Cost-effectiveness of zoledronic acid in the prevention of skeletal-related events in patients with bone metastases secondary to advanced renal cell carcinoma: application to France, Germany, and the United Kingdom</title>
            <link>http://www.medworm.com/index.php?rid=3932125&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F62414516186l82r4%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The present analysis suggests that ZOL saves costs and increases QALYs compared to placebo in French, German, and UK RCC patients
 with bone metastases. Additional prospective research may be needed to confirm these results in a larger sample of patients.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s10198-010-0272-0Authors
		M. F. Botteman, Health Economics, Pharmerit International, 4530 East-West Highway, #430, Bethesda, MD 20814, USAM. Meijboom, Health Economics, Pharmerit International, Rotterdam, The NetherlandsI. Foley, Health Economics, Pharmerit International, 4530 East-West Highway, #430, Bethesda, MD 20814, USAJ. M. Stephens, Health Economics, Pharmerit International, 4530 East-West Highway, #430, Bethesda, MD 20814, USAY. M. Chen, Health Economics, Nov...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3932125</comments>
            <pubDate>Thu, 02 Sep 2010 06:36:44 +0100</pubDate>
            <guid isPermaLink="false">3932125</guid>        </item>
        <item>
            <title>The impact of repeated cost containment policies on pharmaceutical expenditure: experience in Spain</title>
            <link>http://www.medworm.com/index.php?rid=3932124&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe008gr7416205k61%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The growth in expenditure on the financing of pharmaceuticals is a factor that accounts for a large part of the increase in
 public health spending in most developed countries. In an attempt to kerb this growth, many health authorities, particularly
 in Europe, have introduced numerous regulatory measures that have affected the market, especially on the supply side. These
 measures include the system of reference pricing, the reduction of wholesale distributors’ and retailers’ markups and compulsory
 reductions of ex-factory prices. We assess the impact of these cost containment measures on expenditure per capita, prescriptions
 per capita and the average price of pharmaceuticals financed by the public sector in Catalonia (Spain), from 1995 to 2006.
 We apply an aut...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3932124</comments>
            <pubDate>Thu, 02 Sep 2010 06:36:44 +0100</pubDate>
            <guid isPermaLink="false">3932124</guid>        </item>
        <item>
            <title>Erratum to: Hospital’s activity-based financing system and manager–physician interaction</title>
            <link>http://www.medworm.com/index.php?rid=3919246&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm405741475577wx6%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s10198-010-0275-xAuthors
		David Crainich, CNRS/LEM (UMR 8179), IÉSEG School of Management, Lille, FranceHervé Leleu, CNRS/LEM (UMR 8179), IÉSEG School of Management, Lille, FranceAna Mauleon, FNRS and CEREC, Facultés Universitaires Saint-Louis, and CORE, UCLouvain, Brussels, Belgium
	

	
		Journal The European Journal of Health EconomicsOnline ISSN 1618-7601Print ISSN 1618-7598 (Source: The European Journal of Health Economics)</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3919246</comments>
            <pubDate>Mon, 30 Aug 2010 05:53:13 +0100</pubDate>
            <guid isPermaLink="false">3919246</guid>        </item>
        <item>
            <title>Reimbursement of pharmaceuticals: reference pricing versus health technology assessment</title>
            <link>http://www.medworm.com/index.php?rid=3919247&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fnl71431ru0308682%2F</link>
            <description>This study focussed on decisions about the initial price and reimbursement status of innovative drugs and
 discussed the consequences for market access and cost. Four countries were studied: Germany, The Netherlands, Sweden and the
 United Kingdom. These countries have operated one, or both, of the two policies at certain points in time, sometimes in parallel.
 Drugs in four groups were considered: cholesterol-lowering agents, insulin analogues, biologic drugs for rheumatoid arthritis
 and “atypical” drugs for schizophrenia. Compared with HTA, reference pricing is a relatively blunt instrument for obtaining
 value for money from pharmaceuticals. Thus, its role in making reimbursement decisions should be limited to drugs which are
 therapeutically equivalent. HTA is a superior strategy ...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3919247</comments>
            <pubDate>Sat, 28 Aug 2010 05:56:14 +0100</pubDate>
            <guid isPermaLink="false">3919247</guid>        </item>
        <item>
            <title>How removing prescription drugs from reimbursement lists increases the pharmaceutical expenditures for alternatives</title>
            <link>http://www.medworm.com/index.php?rid=3884235&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx7t9867n06357u41%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Changing the status of drugs from prescription-only to over-the-counter and removing them from reimbursement list has been
 used as a cost reduction measure by several third-party payers. In June 2006, the Turkish government, in an effort to curtail
 costs, removed many prescription drugs from the reimbursement list. This paper examines the effect of this policy on the expenditures
 for drugs that were removed from the reimbursement list and for their reimbursable alternatives that can be prescribed by
 physicians on patient request. To accomplish these goals, actual expenditures in four anatomical therapeutic chemical (ATC)
 groups were compared with expected expenditures in the absence of policy change for both removed and alternative drugs. The findings indicated tha...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3884235</comments>
            <pubDate>Wed, 18 Aug 2010 06:46:27 +0100</pubDate>
            <guid isPermaLink="false">3884235</guid>        </item>
        <item>
            <title>Cost-effectiveness of cognitive-behavioral group therapy for dysfunctional fear of progression in cancer patients</title>
            <link>http://www.medworm.com/index.php?rid=3833060&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq38217136qh3472l%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Anxiety and fear are often associated with chronic conditions such as cancer. This paper targets the cost-effectiveness analysis
 of a cognitive-behavioral group therapy (CBT) in comparison to a client-centered, supportive-experiential group therapy (SET)
 in cancer patients with dysfunctional fear of progression. An incremental cost-effectiveness analysis was performed using
 data from a randomized controlled trial among cancer patients receiving inpatient rehabilitation. The means, 95% confidence
 intervals [95% CI], incremental cost-effectiveness graphic and acceptability curve were obtained from 1,000 bootstrap replications.
 A total of 174 patients were included in the economic evaluation. The estimated means [95% CI] of direct costs and reduction
 of fear of progr...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3833060</comments>
            <pubDate>Fri, 06 Aug 2010 07:46:23 +0100</pubDate>
            <guid isPermaLink="false">3833060</guid>        </item>
        <item>
            <title>EJHE has an official impact factor of 1.337</title>
            <link>http://www.medworm.com/index.php?rid=3820014&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7211587907026827%2F</link>
            <description>Content Type Journal ArticleCategory EditorialDOI 10.1007/s10198-010-0269-8Authors
		J.-Matthias Graf von der Schulenburg, Leibniz Universität Hannover Königsworther Platz 1 30167 Hannover Germany
	

	
		Journal The European Journal of Health EconomicsOnline ISSN 1618-7601Print ISSN 1618-7598 (Source: The European Journal of Health Economics)</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3820014</comments>
            <pubDate>Tue, 03 Aug 2010 17:23:58 +0100</pubDate>
            <guid isPermaLink="false">3820014</guid>        </item>
        <item>
            <title>Exploring the relationship between costs and quality: Does the joint evaluation of costs and quality alter the ranking of Danish hospital departments?</title>
            <link>http://www.medworm.com/index.php?rid=3820015&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw5w0285811715850%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Compared to benchmarking of departments based solely on their costs, we show that the ranking of departments may be altered
 considerably when quality is taken into account. Consequently, it is important to have a well-rounded view of departmental
 objectives when undertaking performance evaluation. The results for mortality may lend some support to the theory of a U-shaped
 cost/quality relationship. However, the results for wound complications do not support the theory of a U-shaped cost/quality
 relationship.
 
 
 
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s10198-010-0268-9Authors
		Anne Hvenegaard, Danish Institute for Health Services Research 27-29 Dampfaergevej 2100 Copenhagen DenmarkJacob Nielsen Arendt, University of Southern Denmark I...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3820015</comments>
            <pubDate>Mon, 02 Aug 2010 20:01:20 +0100</pubDate>
            <guid isPermaLink="false">3820015</guid>        </item>
        <item>
            <title>Cost efficiency of university hospitals in the Nordic countries: a cross-country analysis</title>
            <link>http://www.medworm.com/index.php?rid=3807147&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F61l7365447544696%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;This paper estimates cost efficiency scores using the bootstrap bias-corrected procedure, including variables for teaching
 and research, for the performance of university hospitals in the Nordic countries. Previous research has shown that hospital
 provision of research and education interferes with patient care routines and inflates the costs of health care services,
 turning university hospitals into outliers in comparative productivity and efficiency analyses. The organisation of patient
 care, medical education and clinical research as well as available data at the university hospital level are highly similar
 in the Nordic countries, creating a data set of comparable decision-making units suitable for a cross-country cost efficiency
 analysis. The results demonstr...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3807147</comments>
            <pubDate>Thu, 29 Jul 2010 16:06:19 +0100</pubDate>
            <guid isPermaLink="false">3807147</guid>        </item>
        <item>
            <title>The convergence of health care financing structures: empirical evidence from OECD-countries</title>
            <link>http://www.medworm.com/index.php?rid=3775433&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp740158212t11214%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The convergence/divergence of health care systems between countries is an interesting facet of the health care system research
 from a macroeconomic perspective. In this paper, we concentrate on an important dimension of every health care system, namely
 the convergence/divergence of health care financing (HCF). Based on data from 22 OECD countries in the time period 1970–2005,
 we use the public financing ratio (public financing in % of total HCF) and per capita public HCF as indicators for convergence.
 By applying different concepts of convergence, we find that HCF is converging. This conclusion also holds when we look at
 smaller subgroups of countries and shorter time periods. However, we find evidence that countries do not move towards a common
 mean and that th...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3775433</comments>
            <pubDate>Sat, 17 Jul 2010 21:11:20 +0100</pubDate>
            <guid isPermaLink="false">3775433</guid>        </item>
        <item>
            <title>Direct costs of Alzheimer’s disease in Germany</title>
            <link>http://www.medworm.com/index.php?rid=3775434&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff3374w64p4357l78%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The results demonstrate that non-antidementive therapy for Alzheimer’s disease causes higher costs especially for care. The
 memantine group proved to be superior compared to PHS group and no AT group, despite higher costs in the specific drug category.
 
 
 
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s10198-010-0267-xAuthors
		Peter Kiencke, Institute of Empirical Health Economics Am Ziegelfeld 28 51399 Burscheid GermanyDietmar Daniel, Institute of Empirical Health Economics Am Ziegelfeld 28 51399 Burscheid GermanyChristine Grimm, Institute of Empirical Health Economics Am Ziegelfeld 28 51399 Burscheid GermanyReinhard Rychlik, Institute of Empirical Health Economics Am Ziegelfeld 28 51399 Burscheid Germany
	

	
		Journal The European Journal...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3775434</comments>
            <pubDate>Sat, 17 Jul 2010 21:11:19 +0100</pubDate>
            <guid isPermaLink="false">3775434</guid>        </item>
        <item>
            <title>Do you believe in magic? Improving the quality of pharmacy services through restricting entry and aspirational contracts, the Irish experience</title>
            <link>http://www.medworm.com/index.php?rid=3742049&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F75704u5kl65j2754%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A constant refrain of policy makers and public representatives is the necessity of improving the quality of public health
 services. In this paper, two inter-related policies designed to raise the quality of pharmacy services in Ireland are considered.
 The first was to restrict the opening of new pharmacies, the second to increase the quality of pharmacy services through contract
 specification. While the first policy restricted entry and raised returns to existing pharmacies, there is no evidence it
 raised service quality. Equally, the second policy appears to have had little effect on the quality of pharmacy services.
 The contractual provision itself is largely unenforceable, does not recognize the conflicting motivations of a pharmacist
 and results in no measurab...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3742049</comments>
            <pubDate>Thu, 08 Jul 2010 16:18:35 +0100</pubDate>
            <guid isPermaLink="false">3742049</guid>        </item>
        <item>
            <title>Comparison of cost-weights scales methodologies in the perspective of a financing system based on pathologies</title>
            <link>http://www.medworm.com/index.php?rid=3736114&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7m76v22384681t56%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The cost database created made it possible to create a CW scale according to a technique which could constitute the first
 step of a PPS if advantages of a such financing system were established. In the Belgian context, it would be probably judicious
 to envisage regional databases allowing diversified methodological approaches whose results would be confronted, discussed,
 and coordinated at the federal level.
 
 
 
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s10198-010-0262-2Authors
		M. Pirson, Ecole de Santé Publique de l’Université Libre de Bruxelles Département d’Economie de la Santé, CP592 806, Route de Lennik 1070 Bruxelles BelgiumC. Delo, Ecole de Santé Publique de l’Université Libre de Bruxelles Département d’Economie de...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3736114</comments>
            <pubDate>Tue, 06 Jul 2010 17:01:27 +0100</pubDate>
            <guid isPermaLink="false">3736114</guid>        </item>
        <item>
            <title>Atrial fibrillation: the cost of illness in Sweden</title>
            <link>http://www.medworm.com/index.php?rid=3717422&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fuq6l152314707217%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;This is a comprehensive, nation-based cost analysis of AF where relevant data were derived from national registries covering
 the entire Swedish population. The results showed that the annual cost of AF was high in comparison with other diseases, but
 likely to be underestimated as a conservative approach was applied in the analysis.
 
 
 
 
	Content Type Journal ArticleCategory Original paperDOI 10.1007/s10198-010-0261-3Authors
		Lisa Ericson, Nordic Health Economic Research Sahlgrenska Science Park, Medicinaregatan 8a 413 46 Gothenburg SwedenLennart Bergfeldt, University of Gothenburg Department of Molecular and Clinical Medicine/Cardiology, Sahlgrenska Academy Gothenburg SwedenIngela Björholt, Nordic Health Economic Research Sahlgrenska Science Park, Medicinaregat...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3717422</comments>
            <pubDate>Wed, 30 Jun 2010 16:46:08 +0100</pubDate>
            <guid isPermaLink="false">3717422</guid>        </item>
        <item>
            <title>Ageing and health care expenditure in EU-15</title>
            <link>http://www.medworm.com/index.php?rid=3709486&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9j07k27w375n5051%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The purpose of this paper is to investigate the relationship between ageing and the evolution of health care expenditure per
 capita in the EU-15 countries. A secondary purpose is to produce estimates that can be used in projections of future health
 care costs. Explanatory variables include economic, social, demographic and institutional variables as well as variables related
 to capacity and production technology in the health care sector. The study applies a co-integrated panel data regression approach
 to derive short-run relationships and furthermore reports long-run relationships between health care expenditure and the explanatory
 variables. Our findings suggest that there is a positive short-run effect of ageing on health care expenditure, but that the
 long-run...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3709486</comments>
            <pubDate>Fri, 25 Jun 2010 17:07:38 +0100</pubDate>
            <guid isPermaLink="false">3709486</guid>        </item>
        <item>
            <title>Cost study of the clinical management of prostate cancer in France: results on the basis of population-based data</title>
            <link>http://www.medworm.com/index.php?rid=3670203&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fbn261863331p8676%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Prostate cancer is an important disease in terms of economic implications because of its increasing incidence and health care
 costs. We assessed the direct costs of the clinical management of prostate cancer in France. A retrospective study based on
 population-based data was carried out. Eight hundred and seventy-nine cases of prostate cancer diagnosed in five departments
 were included in a 5-year follow-up study. The economic analysis adopted the health-care payer’s perspective and took into
 account only the direct costs. The mean cost of managing patients was estimated at &amp;#8364;12,731. It is composed of 49 to 82% of
 initial treatments according to the therapeutic strategy. The follow-up constituted between 3 and 11%, the costs of treatments
 for side effects b...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3670203</comments>
            <pubDate>Mon, 14 Jun 2010 14:15:43 +0100</pubDate>
            <guid isPermaLink="false">3670203</guid>        </item>
        <item>
            <title>Feeding the economics of obesity in the EU in a healthy way</title>
            <link>http://www.medworm.com/index.php?rid=3651385&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj336xn4228686775%2F</link>
            <description>Content Type Journal ArticleCategory EditorialDOI 10.1007/s10198-010-0259-xAuthors
		Fernando Antonanzas, University of La Rioja Department of Economics 26004 Logrono SpainRoberto Rodríguez, University of La Rioja Department of Economics 26004 Logrono Spain
	

	
		Journal The European Journal of Health EconomicsOnline ISSN 1618-7601Print ISSN 1618-7598 (Source: The European Journal of Health Economics)</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3651385</comments>
            <pubDate>Mon, 07 Jun 2010 16:13:16 +0100</pubDate>
            <guid isPermaLink="false">3651385</guid>        </item>
        <item>
            <title>Cost of low back pain in Switzerland in 2005</title>
            <link>http://www.medworm.com/index.php?rid=3643746&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fdl542687651271p5%2F</link>
            <description>This study estimated the total cost of LBP in Switzerland in 2005 from a societal perspective using a bottom-up
 prevalence-based cost-of-illness approach. The study considers more cost categories than are typically investigated and includes
 the costs associated with a multitude of LBP sufferers who are not under medical care. The findings are based on a questionnaire
 completed by a sample of 2,507 German-speaking respondents, of whom 1,253 suffered from LBP in the last 4&amp;nbsp;weeks; 346 of them
 were receiving medical treatment for their LBP. Direct costs of LBP were estimated at &amp;#8364;2.6&amp;nbsp;billion and direct medical costs
 at 6.1% of the total healthcare expenditure in Switzerland. Productivity losses were estimated at &amp;#8364;4.1&amp;nbsp;billion with the human
 capital approach and &amp;...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3643746</comments>
            <pubDate>Fri, 04 Jun 2010 16:51:19 +0100</pubDate>
            <guid isPermaLink="false">3643746</guid>        </item>
        <item>
            <title>Largely ignored: the impact of the threshold value for a QALY on the importance of a transferability factor</title>
            <link>http://www.medworm.com/index.php?rid=3628477&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fep862q6r6u076p41%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Recently, several checklists systematically assessed factors that affect the transferability of cost-effectiveness (CE) studies
 between jurisdictions. The role of the threshold value for a QALY has been given little consideration in these checklists,
 even though the importance of a factor as a cause of between country differences in CE depends on this threshold. In this
 paper, we study the impact of the willingness-to-pay (WTP) per QALY on the importance of transferability factors in the case
 of smoking cessation support (SCS). We investigated, for several values of the WTP, how differences between six countries
 affect the incremental net monetary benefit (INMB) of SCS. The investigated factors were demography, smoking prevalence, mortality,
 epidemiology and costs...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3628477</comments>
            <pubDate>Sat, 29 May 2010 16:54:16 +0100</pubDate>
            <guid isPermaLink="false">3628477</guid>        </item>
        <item>
            <title>Hospital’s activity-based financing system and manager: physician interaction</title>
            <link>http://www.medworm.com/index.php?rid=3602399&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fgk8615336l0q6662%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;This paper examines the consequences of the introduction of an activity-based reimbursement system on the behavior of physicians
 and hospital’s managers. We consider a private for-profit sector where both hospitals and physicians are initially paid on
 a fee-for-service basis. We show that the benefit of the introduction of an activity-based system depends on the type of interaction
 between managers and physicians (simultaneous or sequential decision-making games). It is shown that, under the activity-based
 system, a sequential interaction with physician leader could be beneficial for both agents in the private sector. We further
 model an endogenous timing game à la Hamilton and S.sky (Games Econ Behav 2: 29–46, 1990) in which the type of interaction is determi...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3602399</comments>
            <pubDate>Mon, 24 May 2010 16:25:48 +0100</pubDate>
            <guid isPermaLink="false">3602399</guid>        </item>
        <item>
            <title>Contractual conditions, working conditions and their impact on health and well-being</title>
            <link>http://www.medworm.com/index.php?rid=3602400&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0663263v846452g6%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Given changes in the labour market in past decades, it is of interest to evaluate whether and how contractual and working
 conditions affect health and psychological well-being in society today. We consider the effects of contractual and working
 conditions on self-assessed health and psychological well-being using twelve waves (1991/1992–2002/2003) of the British Household
 Panel Survey. For self-assessed health, the dependent variable is categorical, and we estimate non-linear dynamic panel ordered
 probit models, while for psychological well-being, we estimate a dynamic linear specification. The results show that both
 contractual and working conditions have an influence on health and psychological well-being and that the impact is different
 for men and women.
 
 ...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3602400</comments>
            <pubDate>Mon, 24 May 2010 16:25:46 +0100</pubDate>
            <guid isPermaLink="false">3602400</guid>        </item>
        <item>
            <title>Factors associated with the use of primary care services: the role of practice nurses</title>
            <link>http://www.medworm.com/index.php?rid=3602401&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr57u5272251147jw%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Rising demand for and costs of health care have led to an increasing role of practice nurses in primary care in many countries,
 including the United Kingdom. Previous research has explored how practice nurse care differs from that provided by general
 practitioners (GPs) in terms of costs and health outcomes, and has highlighted the importance of matching skills and experience
 with roles and responsibilities. However, there has been little research to compare the characteristics of patients seen by
 GPs and practice nurses in primary care. We aim to investigate the factors associated with the use of practice nurse visits,
 and to compare these with the factors associated with GP use. We jointly model the use of practice nurse and GP visits using
 a bivariate probit re...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3602401</comments>
            <pubDate>Sat, 22 May 2010 16:48:40 +0100</pubDate>
            <guid isPermaLink="false">3602401</guid>        </item>
        <item>
            <title>Discrimination in waiting times by insurance type and financial soundness of German acute care hospitals</title>
            <link>http://www.medworm.com/index.php?rid=3602403&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F960u656761247832%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;This paper shows that patients with private health insurance (PHI) are being offered significantly shorter waiting times than
 patients with statutory health insurance (SHI) in German acute hospital care. This behavior may be driven by the higher expected
 profitability of PHI relative to SHI holders. Further, we find that hospitals offering private insurees shorter waiting times
 when compared with SHI holders have a significantly better financial performance than those abstaining from or with less discrimination.
 
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s10198-010-0254-2Authors
		Christoph Schwierz, KCE Belgian Health Care Knowledge Centre Boulevard du Jardin Botanique, 55 1000 Brussels BelgiumAchim Wübker, Universität Osnabrück Albrechts...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3602403</comments>
            <pubDate>Sat, 22 May 2010 16:48:39 +0100</pubDate>
            <guid isPermaLink="false">3602403</guid>        </item>
        <item>
            <title>Comparing top-down and bottom-up costing approaches for economic evaluation within social welfare</title>
            <link>http://www.medworm.com/index.php?rid=3602402&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh950k21134656707%2F</link>
            <description>This study compares two approaches to the estimation of social welfare intervention costs: one “top-down” and the other “bottom-up”
 for a group of social welfare clients with severe problem behavior participating in a randomized trial. Intervention costs
 ranging over a two-year period were compared by intervention category (foster care placement, institutional placement, mentorship
 services, individual support services and structured support services), estimation method (price, micro costing, average cost)
 and treatment group (intervention, control). Analyses are based upon 2007 costs for 156 individuals receiving 404 interventions.
 Overall, both approaches were found to produce reliable estimates of intervention costs at the group level but not at the
 individual level. As ch...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3602402</comments>
            <pubDate>Sat, 22 May 2010 16:48:39 +0100</pubDate>
            <guid isPermaLink="false">3602402</guid>        </item>
        <item>
            <title>Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences</title>
            <link>http://www.medworm.com/index.php?rid=3572595&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl501818k23p54664%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Mapping from QLQ-C30 scores to EQ-5D-derived utilities when only QLQ-C30 data are available has been shown to be possible
 with good accuracy. Validation of the proposed algorithm in other external clinical datasets should be encouraged.
 
 
 
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s10198-010-0233-7Authors
		Ralph Crott, Catholic University of Louvain Academic Hospital St Luc 10 Avenue Hippocrate Brussels 1200 BelgiumAndrew Briggs, University of Glasgow Section of Public Health and Health, Division of Community Based Sciences, Faculty of Medicine Glasgow UK
	

	
		Journal The European Journal of Health EconomicsOnline ISSN 1618-7601Print ISSN 1618-7598 (Source: The European Journal of Health Economics)</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3572595</comments>
            <pubDate>Sun, 16 May 2010 07:02:52 +0100</pubDate>
            <guid isPermaLink="false">3572595</guid>        </item>
        <item>
            <title>Use of formal and informal care services among older people in Ireland and France</title>
            <link>http://www.medworm.com/index.php?rid=3572596&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu200754275866375%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;This paper focuses on current use of elderly care services in Ireland and France. In light of health care resource allocation
 problems, it is important to know the level of current use of home care on which future projections may be based. With the
 availability of SHARE (Survey of Health Ageing and Retirement in Europe) data, it is now possible to analyse this process
 and estimate the relationship between formal and informal care, and our econometric model tests for endogeneity of informal
 care. Previous research has not included Ireland into the analysis. Given that Ireland has a younger population base, lessons
 could be learned from countries with older populations, such as France. Results suggest informal care is endogenous and negatively
 linked with formal car...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3572596</comments>
            <pubDate>Sat, 15 May 2010 08:11:05 +0100</pubDate>
            <guid isPermaLink="false">3572596</guid>        </item>
        <item>
            <title>The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure</title>
            <link>http://www.medworm.com/index.php?rid=3572597&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk458818535526812%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;In subgroups of patients differing in CHF severity according to the DASI, mean EQ-5D and SF-6D indices differed significantly.
 Contrarily, in socio-demographic and clinical groups, these utility differences were not directly evident. According to the
 evidence, comparisons based on severity classification via a valid disease-specific external instrument may provide insight
 on instrument choice in cost-utility analyses.
 
 
 
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s10198-010-0252-4Authors
		Nick Kontodimopoulos, Hellenic Open University Faculty of Social Sciences Bouboulinas 57 26222 Patras GreeceMichalis Argiriou, Hellenic Open University Faculty of Social Sciences Bouboulinas 57 26222 Patras GreeceNikolaos Theakos, Evangelismos Hospital ...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3572597</comments>
            <pubDate>Sat, 15 May 2010 08:11:04 +0100</pubDate>
            <guid isPermaLink="false">3572597</guid>        </item>
        <item>
            <title>Severity as an independent determinant of the social value of a health service</title>
            <link>http://www.medworm.com/index.php?rid=3555021&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F291538748413k62p%2F</link>
            <description>We present data consistent with the view that after taking account of health improvement, health programs are
 preferred which do not leave people in severe health states. Alternative explanations are considered and particularly the
 possibility that data reflect a social preference for individuals achieving their health potential. Both explanations imply
 the need to reconsider the rules for prioritising programs. In this analysis, Person Trade-Off (PTO) scores are used to measure
 social preferences (‘value’ or ‘social utility’) and Time Trade-Off (TTO) scores are used to measure individual assessments
 of health improvement and initial severity. Econometric results suggest that severity is highly significant and may more than
 double the index of social value of a health service...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3555021</comments>
            <pubDate>Sun, 09 May 2010 09:48:43 +0100</pubDate>
            <guid isPermaLink="false">3555021</guid>        </item>
        <item>
            <title>Preferences for health insurance and health status: does it matter whether you are Dutch or German?</title>
            <link>http://www.medworm.com/index.php?rid=3544827&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp147j7j57q868241%2F</link>
            <description>The objective is to test the presumption that preferences between these two subpopulations
 differ and to see whether having a chronic condition has a different influence on preferences depending on the country. The
 evidence comes from two Discrete Choice Experiments performed in 2005 (Germany) and 2006 (the Netherlands, right after a major
 health reform). Results point to an even more marked resistance against restrictions of physician choice among individuals
 with chronic conditions in both countries. Thus, the alleged beneficiaries of Disease Management Programs would have to be
 highly compensated for accepting the restrictions that go with them.
 
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s10198-010-0248-0Authors
		Janet MacNeil Vroomen, University of Zurich...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3544827</comments>
            <pubDate>Thu, 06 May 2010 09:02:03 +0100</pubDate>
            <guid isPermaLink="false">3544827</guid>        </item>
        <item>
            <title>Incentives in primary care and their impact on potentially avoidable hospital admissions</title>
            <link>http://www.medworm.com/index.php?rid=3518276&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1r0hu62k008h33j0%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Financial incentives in primary care have been introduced with the purpose of improving appropriateness of care and containing
 demand. We usually observe pay-for-performance programs, but alternatives, such as pay-for-participation in improvement activities
 and pay-for-compliance with clinical guidelines, have also been implemented. Here, we assess the influence of different programs
 that ensure extra payments to GPs for containing avoidable hospitalisations. Our dataset covers patients and GPs of the Italian
 region Emilia-Romagna for the year 2005. By separating pay-for-performance from pay-for-participation and pay-for-compliance
 programs, we estimate the impact of different financial incentives on the probability of avoidable hospitalisations. As dependent
 vari...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3518276</comments>
            <pubDate>Wed, 28 Apr 2010 08:03:37 +0100</pubDate>
            <guid isPermaLink="false">3518276</guid>        </item>
        <item>
            <title>Economic evaluation of irbesartan in combination with hydrochlorothiazide in the treatment of hypertension in Greece</title>
            <link>http://www.medworm.com/index.php?rid=3502625&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe7688232h8261234%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Based on efficacy data from clinical trials and lower attainment costs in various hypertensive patient populations, irbesartan
 in combination with HCTZ compares favorably with losartan and valsartan in combination with HCTZ in the Greek setting.
 
 
 
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s10198-010-0243-5Authors
		Nikos Maniadakis, National School of Public Health Department of Health Services Management 196 Alexandras Avenue 115 22 Athens GreeceMattias Ekman, i3 Innovus, Vasagatan 38 111 20 Stockholm SwedenVasilios Fragoulakis, National School of Public Health Department of Health Services Management 196 Alexandras Avenue 115 22 Athens GreeceVasiliki Papagiannopoulou, National Centre for Social Research Department of Health Economics 14...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3502625</comments>
            <pubDate>Thu, 22 Apr 2010 09:22:56 +0100</pubDate>
            <guid isPermaLink="false">3502625</guid>        </item>
        <item>
            <title>Spanish recommendations on economic evaluation of health technologies</title>
            <link>http://www.medworm.com/index.php?rid=3493363&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F068123636t8tq805%2F</link>
            <description>The objective of this proposal was to develop guidelines for the
 economic evaluation of health technologies in Spain. A group of researchers specialized in economic evaluation of health technologies
 developed the document reported here, following the initiative of other countries in this framework, to provide recommendations
 for the standardization of methodology applicable to economic evaluation of health technologies in Spain. Recommendations
 appear under 17 headings or sections. In each case, the recommended requirements to be satisfied by economic evaluation of
 health technologies are provided. Each recommendation is followed by a commentary providing justification and compares and
 contrasts the proposals with other available alternatives. The economic evaluation of health techno...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3493363</comments>
            <pubDate>Tue, 20 Apr 2010 10:55:09 +0100</pubDate>
            <guid isPermaLink="false">3493363</guid>        </item>
        <item>
            <title>Modelling the costs of care of hypertension in patients with metabolic syndrome and its consequences, in Germany, Spain and Italy</title>
            <link>http://www.medworm.com/index.php?rid=3493364&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp0518603g5447w22%2F</link>
            <description>In conclusion, the presence of MetS in patients
 with hypertension significantly inflates economic burden, and costs are likely to increase in the future due to an aging population
 and an increase in the prevalence of components of MetS.
 
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s10198-010-0223-9Authors
		Eberhard Wille, Fakultät für Volkswirtschaftslehre L 7, 3-5, 2. OG, Raum 21 68131 Mannheim GermanyJürgen Scholze, Charite-Universitatsmedizin Berlin Department of Medicine, Outpatient Clinic, CCM Luisenstrasse 11-13 10117 Berlin GermanyEduardo Alegria, Policlínica Gipuzkoa Servicio de Cardiología San Sebastián SpainClaudio Ferri, University of L’Aquila Division of Internal Medicine, Hypertension and Cardiovascular Prevention Center, Department of Interna...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3493364</comments>
            <pubDate>Tue, 20 Apr 2010 10:55:07 +0100</pubDate>
            <guid isPermaLink="false">3493364</guid>        </item>
        <item>
            <title>Future challenges for health economics and health technology assessment of biological drugs</title>
            <link>http://www.medworm.com/index.php?rid=3485830&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh109250114327813%2F</link>
            <description>Content Type Journal ArticleCategory EditorialDOI 10.1007/s10198-010-0246-2Authors
		László Gulácsi, Corvinus University of Budapest Health Economics and Health Technology Assessment Research Centre Fovam ter 8 1093 Budapest Hungary
	

	
		Journal The European Journal of Health EconomicsOnline ISSN 1618-7601Print ISSN 1618-7598 (Source: The European Journal of Health Economics)</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3485830</comments>
            <pubDate>Sat, 17 Apr 2010 16:49:35 +0100</pubDate>
            <guid isPermaLink="false">3485830</guid>        </item>
        <item>
            <title>Additional costs of inpatient malnutrition, Victoria, Australia, 2003–2004</title>
            <link>http://www.medworm.com/index.php?rid=3485829&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr8723737317u3050%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Our objective was to estimate the cost of inpatient malnutrition conditional upon admitting diagnosis and recorded nutritional
 treatment. We analysed an anonymised administrative data set for inpatients treated in hospitals in Victoria, Australia 2003–2004.
 The data set included patient-level cost, clinical markers, demographic and episode variables. The data set was analysed to
 identify codes, which indicated the presence of malnutrition or its treatment. Linear regression was used to ascertain to
 what extent malnutrition affected the cost of admission. Controlling for the underlying condition and any treatment administered,
 recorded malnutrition is estimated to add AU 1,745 per admission. The total cost of coded malnutrition to the Victorian public hospital sys...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3485829</comments>
            <pubDate>Sat, 17 Apr 2010 16:49:35 +0100</pubDate>
            <guid isPermaLink="false">3485829</guid>        </item>
        <item>
            <title>Health burden and costs of obesity and overweight in Germany</title>
            <link>http://www.medworm.com/index.php?rid=3485831&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq026488133011l43%2F</link>
            <description>This study aimed to estimate the health burden and the direct as well as indirect costs of morbidity and mortality attributable
 to obesity and overweight in Germany for the year 2002. We used the concept of attributable fractions based on German prevalence
 data and relative risks from US studies as well as routine statistics. We estimated obesity- and overweight-attributable deaths,
 years of potential life lost (YPLL) and quality-adjusted life years lost (QALY) for various diseases associated with obesity
 and overweight. Direct costs were estimated for inpatient and outpatient treatment, rehabilitation and non-medical costs.
 Indirect costs were estimated for sickness absence, early retirement and mortality using the human capital approach. We estimated
 36,653 obesity- and overweight-...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3485831</comments>
            <pubDate>Sat, 17 Apr 2010 16:49:34 +0100</pubDate>
            <guid isPermaLink="false">3485831</guid>        </item>
        <item>
            <title>Deriving reference values and utilities for the QoL-AGHDA in adult GHD</title>
            <link>http://www.medworm.com/index.php?rid=3482310&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F03486607x2218867%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Interventions in GHD can now be evaluated more validly in Belgium and the Netherlands.
 
 
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s10198-010-0241-7Authors
		J. J. V. Busschbach, Medical Psychology and Psychotherapy, Erasmus MC P.O. Box 2040 3000 CA Rotterdam The NetherlandsB. H. R. Wolffenbuttel, University Medical Centre Groningen, University of Groningen Department of Endocrinology HPC AA31 P.O. Box 30001 9700 RB Groningen The NetherlandsL. Annemans, Ghent University Department of Public Health, Faculty of Medicine and Health Sciences De Pintelaan 185 Bl.A-1 9000 Ghent BelgiumW. J. Meerding, Pfizer BV Rivium Westlaan 142 2909 LD Capelle a/d IJssel The NetherlandsM. Kołtowska-Häggström, KIMS Medical Outcomes, Pfizer Endocrine Care Veten...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3482310</comments>
            <pubDate>Fri, 16 Apr 2010 16:51:37 +0100</pubDate>
            <guid isPermaLink="false">3482310</guid>        </item>
        <item>
            <title>Economic policies for healthier food intake: the impact on different household categories</title>
            <link>http://www.medworm.com/index.php?rid=3470924&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu24100374620l6l3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;This paper simulates the impact across household types of fully funded tax reforms designed to increase consumers’ fiber intake
 from grain consumption. Our results suggest that household types with the highest initial consumption share of fiber-rich
 products—i.e., households without children (seniors, couples without children, and single women without children)—experience
 the highest increase in fiber intake from these reforms. However, they also experience high increases in unhealthy nutrients
 from the reforms, making the net health effects difficult to evaluate. Seniors and couples without children also gain most
 financially, paying less food taxes and facing, depending on the reform, either a lower price level than before the reform
 or a lower increase in...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3470924</comments>
            <pubDate>Sat, 10 Apr 2010 07:47:34 +0100</pubDate>
            <guid isPermaLink="false">3470924</guid>        </item>
        <item>
            <title>Age effects in monetary valuation of reduced mortality risks: the relevance of age-specific hazard rates</title>
            <link>http://www.medworm.com/index.php?rid=3452592&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4x5q7520026r0454%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;This paper highlights the relevance of age-specific hazard rates in explaining the age variation in “value of statistical
 life” (VSL) figures. The analysis—which refers to a stated preference framework—contributes to the ongoing discussion of whether
 benefits resulting from reduced mortality risk should be valued differently depending on the age of the beneficiaries. By
 focussing on a life-threatening environmental phenomenon I show that the consideration of the individual’s age-specific hazard
 rate is important. If a particular risk affects all individuals regardless of their age so that their hazard rate is age-independent,
 VSL is rather constant for people at different age; if hazard rate varies with age, VSL estimates are sensitive to age. The
 result...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3452592</comments>
            <pubDate>Wed, 07 Apr 2010 19:19:52 +0100</pubDate>
            <guid isPermaLink="false">3452592</guid>        </item>
        <item>
            <title>Resource use and costs of treating acute cough/lower respiratory tract infections in 13 European countries: results and challenges</title>
            <link>http://www.medworm.com/index.php?rid=3447700&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft557565714126u5j%2F</link>
            <description>The objectives of this study were to estimate the resource use and cost of treating acute cough/lower respiratory tract infection
 (acute cough/LRTI) in 13 European countries, to explore reasons for differences in cost and to document the challenges that
 researchers face when collecting information on cost alongside multinational studies. Data on resource use and cost were collected
 alongside an observational study in 14 primary care networks across 13 European countries and a mean cost was generated for
 each network. The results show that the mean cost (standard deviation) of treating acute cough/LRTI in Europe ranged from
 &amp;#8364;23.88 (34.67) in Balatonfüred (Hungary) to &amp;#8364;116.47 (34.29) in Jonkoping (Sweden). The observed differences in costs were
 statistically significant (P...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3447700</comments>
            <pubDate>Sat, 03 Apr 2010 07:14:57 +0100</pubDate>
            <guid isPermaLink="false">3447700</guid>        </item>
        <item>
            <title>Practical issues in handling data input and uncertainty in a budget impact analysis</title>
            <link>http://www.medworm.com/index.php?rid=3447701&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ftn6472m472l745l3%2F</link>
            <description>The objective of this paper was to address the importance of dealing systematically and comprehensively with uncertainty in
 a budget impact analysis (BIA) in more detail. The handling of uncertainty in health economics was used as a point of reference
 for addressing the uncertainty in a BIA. This overview shows that standard methods of sensitivity analysis, which are used
 for standard data set in a health economic model (clinical probabilities, treatment patterns, resource utilisation and prices/tariffs),
 cannot always be used for the input data for the BIA model beyond the health economic data set for various reasons. Whereas
 in a health economic model, only limited data may come from a Delphi panel, a BIA model often relies on a majority of data
 taken from a Delphi panel. In additi...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3447701</comments>
            <pubDate>Sat, 03 Apr 2010 07:14:56 +0100</pubDate>
            <guid isPermaLink="false">3447701</guid>        </item>
        <item>
            <title>Analysis of the validity of the vignette approach to correct for heterogeneity in reporting health system responsiveness</title>
            <link>http://www.medworm.com/index.php?rid=3419591&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr245506156l33834%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Despite the growing popularity of the vignette methodology to deal with self-reported, categorical data, the formal evaluation
 of the validity of this methodology is still a topic of research. Some critical assumptions need to hold in order for this
 method to be valid. In this paper we analyse the assumption of “vignette equivalence” using data on health system responsiveness
 contained within the World Health Survey. We perform several tests to check the assumption of vignette equivalence. First,
 we use a test based on the global ordering of the vignettes. A minimal condition for the assumption of vignette equivalence
 to hold is that individual responses are consistent with the global ordering of vignettes. Secondly, using the hierarchical
 ordered probit model...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3419591</comments>
            <pubDate>Sun, 28 Mar 2010 05:51:59 +0100</pubDate>
            <guid isPermaLink="false">3419591</guid>        </item>
        <item>
            <title>Risk and uncertainty in health investment</title>
            <link>http://www.medworm.com/index.php?rid=3412333&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk50t12661g552177%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Extending the Grossman (J Polit Econ 80:223–255, 1972) model of health capital into a stochastic one, we analyze how the presence
 of Knightian uncertainty about the efficacy of health care affects the optimal health investment behavior of individuals.
 Using Gilboa and Schmeidler’s (J Math Econ 18:141–153, 1989) model of maxmin expected utility (MMEU) with multiple priors,
 we show that an agent retains the initial level of health capital if the price of health care lies within a certain range.
 We also show that the no-investment range expands as the degree of Knightian uncertainty rises.
 
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s10198-010-0238-2Authors
		Takao Asano, Okayama University Faculty of Economics 3-1-1 Tsushimanaka, Kita-ku ...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3412333</comments>
            <pubDate>Fri, 26 Mar 2010 19:19:56 +0100</pubDate>
            <guid isPermaLink="false">3412333</guid>        </item>
        <item>
            <title>Estimates of patient costs related with population morbidity: can indirect costs affect the results?</title>
            <link>http://www.medworm.com/index.php?rid=3393731&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5863x456175261px%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A number of health economics studies require patient cost estimates as basic information input. However, the accuracy of cost
 estimates remains generally unspecified. We propose to investigate how the allocation of indirect costs or overheads can affect
 the estimation of patient costs and lead to improvements in the analysis of patient cost estimates. Instead of focussing on
 the costing method, this paper will highlight observed changes in variation explained by a methodology choice. We compare
 four overhead allocation methods for a specific Spanish population adjusted using the Clinical Risk Groups model. Our main
 conclusion is that the amount of global variation explained by the risk adjustment model depends mainly on direct costs, regardless
 of the cost allocat...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3393731</comments>
            <pubDate>Sat, 20 Mar 2010 11:05:41 +0100</pubDate>
            <guid isPermaLink="false">3393731</guid>        </item>
        <item>
            <title>Technical efficiency in primary health care: does quality matter?</title>
            <link>http://www.medworm.com/index.php?rid=3393730&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd576351526554t64%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The accuracy required in the measurement of output is an issue that has as yet still not been satisfactorily addressed in
 empirical research on efficiency in primary health care. We exploit information retrieved from a newly constructed database
 (APEX06) for the Spanish region of Extremadura. The richness of our dataset allows us to consider original synthetic measures
 of output that take into account both the quantity and the quality of services provided by 85 primary care centers (PCCs)
 in 2006. We provide evidence that neglecting the issue of properly accounting for the quality of health services can lead
 to misleading results. Our main finding is that adjusting output for quality has a three-fold effect on efficiency analysis.
 Firstly, inefficiency explains re...</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3393730</comments>
            <pubDate>Sat, 20 Mar 2010 11:05:41 +0100</pubDate>
            <guid isPermaLink="false">3393730</guid>        </item>
        <item>
            <title>The effect of alcoholic beverage excise tax on alcohol-attributable injury mortalities</title>
            <link>http://www.medworm.com/index.php?rid=3393732&amp;cid=s_33421_51_f&amp;fid=33421&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc824712n7301q643%2F</link>
            <description>This study examines the effect of state excise taxes on different types of alcoholic beverages (spirits, wine, and beer) on
 alcohol-attributable injury mortalities—deaths caused by motor vehicle accidents, suicides, homicides, and falls—in the United
 States between 1995 and 2004, using state-level panel data. There is evidence that injury deaths attributable to alcohol respond
 differently to changes in state excise taxes on alcohol-specific beverages. This study examines the direct relationship between
 injury deaths and excise taxes without testing the degree of the association between excise taxes and alcohol consumption.
 The study finds that beer taxes are negatively related to motor vehicle accident mortality, while wine taxes are negatively
 associated with suicides and falls....</description>
            <author>The European Journal of Health Economics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3393732</comments>
            <pubDate>Sat, 20 Mar 2010 11:05:40 +0100</pubDate>
            <guid isPermaLink="false">3393732</guid>        </item>
    </channel>
</rss>

